NOVEMBER 2010
Nastaran Monsef
2 november, urologi, Lunds universitet, kl 09.00, Medelhavet, Wallenberglaboratoriet, Skånes universitetssjukhus, Malmö: Prostate cancer and neuroendocrine differentiation. Molecular aspects in prostate cancer development (Nastaran Monsef). Fakultetsopponent: Jack Schalken, Nederländerna.
Eva Innala
5 november, obstetrik och gynekologi, Umeå universitet, kl 09.00, sal B, 9 tr, byggnad 1D, Tandläkarhögskolan: Acute intermittent porphyria, women and sex hormones. Screening for hepatocellular carcinoma in porphyria (Eva Innala). Fakultetsopponent: Raili Kauppinen, Finland.
Maria Henningson
9 november, klinisk medicin, ssk experimentell onkologi, Lunds universitet, kl 09.00, Segerfalksalen, Wallenberg Neurocentrum: Genetic polymorphisms, IGF-1, and oral contraceptive use in women from high-risk breast cancer families (Maria Henningson). Fakultetsopponent: Per Karlsson.
Malin Hedlund
12 november, medicinsk vetenskap, ssk immunologi, Umeå universitet, kl 09.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: Exosomes and the NKG2D receptor-ligand system in pregnancy and cancer: using stress for survival (Malin Hedlund). Fakultetsopponent: Susanne Gabrielsson.
Réka Conrad
12 november, medicinsk vetenskap, Karolinska institutet, kl 09.00, föreläsningssalen R64, Karolinska universitetssjukhuset, Huddinge: Antitumor effect in allogeneic hematopoietic stem cell transplantation in patients with solid cancer (Réka Conrad). Fakultetsopponent: Olle Korsgren.
Lovisa Farnebo
12 november, öron-, näs- och halssjukdomar, Linköpings universitet, kl 09.00, Elsa Brändströmsalen, Universitetssjukhuset i Linköping: Predictive markers for treatment sensitivity in head and neck squamous cell carcinoma (Lovisa Farnebo). Fakultetsopponent: Antti Mäkitie, Finland.
JUNI 2010
Xiaolian Gu
1 juni, patologi, Umeå universitet, kl 09.00, sal E04, byggnad 6E, Norrlands universitetssjukhus: p63 and epithelial homeostasis – studies of p63 under normal, hyperproliferative and malignant conditions (Xiaolian Gu). Fakultetsopponent: Antonio Costanzo, Italien.
Klas Haraldson
1 juni, cell- och tumörbiologi, Karolinska institutet, kl 13.00, sal E525, MTC, Theorells väg 1: NotI genome scanning to identify unknown cancer associated genes in major human epithelial malignancies (Klas Haraldson). Fakultetsopponent: Zoltán Marcsek, Ungern.
Tamador Elsir
4 juni, medicinsk vetenskap, Karolinska institutet, kl 10.00, föreläsningssalen, CCK, R8:00: Transcription factors PROX1 and p53 in cancer development (Tamador Elsir). Fakultetsopponent: Beatrice Melin.
Martin Rutegård
4 juni, medicinsk vetenskap, Karolinska institutet, kl 10.00, Leksellsalen, Eugeniahemmet, T3, Karolinska universitetssjukhuset, Solna: Oesophageal cancer: on surgery and aetiology (Martin Rutegård). Fakultetsopponent: Bengt Glimelius.
Patrik Romerius
4 juni, klinisk medicin, ssk reproduktion, Lunds universitet, kl 13.00, Jubileumsaulan, ingång 59, Skånes universitetssjukhus, Malmö: Reproductive function in male childhood cancer survivors (Patrik Romerius). Fakultetsopponent: Anders Juul, Danmark.
Annika Lindström
12 juni, gynekologisk onkologi, Umeå universitet, kl 09.00, sal 244, byggnad 7, Norrlands universitetssjukhus: Prognostic facors for squamous cell cervical cancer. Tumor markers, hormones, smoking and S-phase fraction (Annika Lindström). Fakultetsopponent: Sonia Andersson.
Ying Zhao
17 juni, tumörbiologi, Karolinska institutet, kl 10.00, MTC:s föreläsningssal, Theorells väg 1: Pharmacological targeting of p53 pathway alterations in tumors (Ying Zhao). Fakultetsopponent: Giovanni Blandino, Italien.
Kerstin Järås
17 juni, laboratoriemedicin, ssk experimentell klinisk kemi, Lunds universitet, kl 09.00, E:1406, E-huset, Lunds Tekniska högskola: Miniaturised and quantitative techniques targeting pros-tate cancer (Kerstin Järås). Fakultetsopponent: Joshua LaBaer, USA.
Pascal Dammeyer
18 juni, medicinsk vetenskap, Karolinska institutet, kl 09.00, Samuelssonsalen, Scheelelaboratoriet, Scheeles väg 2: Cancer vaccine strategies and studies of human thioredoxin reductase splice variants (Pascal Dammeyer). Fakultetsopponent: Regina Brigelius-Flohé, Tyskland.
Eva Diffner
18 juni, laboratoriemedicin, ssk experimentell patologi, Lunds universitet, kl 13.00, föreläsningssalen, Patologihuset, ingång 78, Skånes universitetssjukhus, Malmö: Responses to tumour initiating factors and regulation of normal and malignant haematopoiesis (Eva Diffner). Fakultetsopponent: Dan Grander.
MAJ 2010
Anna Isinger Ekstrand
6 maj, onkologi, Lunds universitet, kl 09.00, Segerfalksalen, Wallenberg neurocentrum: Genomic profiling, mutations and deranged signaling in esophageal cancer and hereditary colorectal cancer (Anna Isinger Ekstrand). Fakultetsopponent: Beatrice Melin.
Anders Kjellman
7 maj, medicinsk vetenskap, Karolinska institutet, kl 09.00, hörsal 4U Solen, Alfred Nobels allé 8, Karolinska universitetssjukhuset, Huddinge: Prostate cancer – aspects of screening and prognostic factors (Anders Kjellman). Fakultetsopponent: Ola Bratt.
Åsa Lindgren
6 maj, medicinsk vetenskap, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Medicinaregatan 3: The function of natural killer cells in Helicobacter pylori infection and gastric cancer (Åsa Lindgren). Fakultetsopponent: Petter Höglund.
Katarina Öhrling
12 maj, onkologi, Karolinska institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska universitetssjukhuset, Solna: Thymidylate synthase expression and mismatch repair protein expression in colorectal cancer – prognostic and predictive markers? (Katarina Öhrling). Fakultetsopponent: Mef Nilbert, Danmark.
Helena Nord
18 maj, experimentell patologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Application of genomic and expression arrays for identification of new cancer genes (Helena Nord). Fakultetsopponent: David Gisselsson Nord.
Bengt Johansson
21 maj, kirurgi, Örebro universitet, kl 09.00, Wilandersalen, Universitetssjukhuset, Örebro: Long-term outcome research on PDR brachytherapy, with focus on breast, base of tongue and lip cancer (Bengt Johansson). Fakultetsopponent: Jan Nyman.
Elisabet Tina
21 maj, biomedicin, Örebro universitet, kl 13.00, Bohmansalen, B-huset, Universitetssjukhuset, Örebro: Biological markers in breast cancer and acute leukemia with focus on drug resistance (Elisabet Tina). Fakultetsopponent: Jan-Ingvar Jönsson.
Maria Bjurberg
21 maj, onkologi, Lunds universitet, kl 13.00, Segerfalksalen, BMC, Sölvegatan 19: FDG-PET in cervical cancer – translational studies (Maria Bjurberg). Fakultetsopponent: Seija Grenman, Finland.
APRIL 2010
Angelika Danielsson
1 april, klinisk immunologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Adenovirus-mediated gene therapy of prostate cancer (Angelika Danielsson). Fakultetsopponent: Gunnel Halldén, England.
Maria Hietala
9 april, klinisk medicin, ssk experimentell onkologi, Lunds universitet, kl 13.00, Alwallhuset: Impact of lifestyle, hormones and genes on breast cancer (Maria Hietala). Fakultetsopponent: Charlotta Dabrosin.
Ulrika Ericson
10 april, folkhälsovetenskap, ssk nutritionsepidemiologi, Lunds universitet, kl 09.30, aulan, CRC, ingång 72, Skånes universitetssjukhus, Malmö: Folate – associations with breast cancer depending on intake, metabolism, genetic variation and estrogen receptor status (Ulrika Ericson). Fakultetsopponent: Alicja Wolk.
Johan Staaf
15 april, klinisk medicin, ssk onkologi, Lunds universitet, kl 13.00, Segerfalksalen, Wallenberg Neurocentrum: Genomic profiling of breast cancer by microarray-based technology and bioinformatics (Johan Staaf). Fakultetsopponent: Carlos Caldas, England.
Dorthe Johansen
16 april, klinisk medicin, ssk kirurgi, Lunds universitet, kl 13.15, föreläsningssalen, CRC, Skånes universitetssjukhus, Malmö: Metabolic and life-style related risk factors for pancreatic cancer (Dorthe Johansen). Fakultetsopponent: Leif Bergkvist.
Emeli Nilsson
16 april, laboratoriemedicin, ssk tumörbiologi, Lunds universitet, kl 09.00, Jubileumsaulan, Skånes universitetssjukhus, Malmö: Fibroblast growth factor-8 regulaton of breast cancer cell growth (Emeli Nilsson). Fakultetsopponent: Anne E Lykkesfeldt, Danmark.
Birgitta Wallberg
16 april, onkologi/patologi, Karolinska institutet, kl 9.30, Radiumhemmets föreläsningssal, Karolinska universitetssjukhuset, Solna: Breast cancer survivors information needs, attitudes towards illness and quality of life (Birgitta Wallberg). Fakultetsopponent: Bo Nordenskjöld.
Kristin Andersson
22 april, medicinsk mikrobiologi, Lunds universitet, kl 09.00, patologiska institutionens föreläsningssal, ingång 78, Skånes universitetssjukhus, Malmö: Human papillomaviruses in skin cancer and cervical cancer (Kristin Andersson). Fakultetsopponent: Michel Favre, Frankrike.
Zhengwen An
23 april, cancerbiologi, Karolinska institutet, kl 09.30, 9Q Månen, Alfred Nobels allé 8, Huddinge: Integrin-interacting proteins in human cancer progression (Zhengwen An). Fakultetsopponent: Maréne Landström.
Aijun Sun
28 april, onkologi, Umeå universitet, kl 09.00, sal 244, byggnad 7, Norrlands universitetssjukhus: Radolabeled acetate positron emission tomography in oncology imaging (Aijun Sun). Fakultetsopponent: Heikki Minn, Finland.
Anastasios Sofiadis
30 april, medicinsk vetenskap, Karolinska institutet, kl 09.00, Rolf Lufts auditorium, L1:00, CMM: In search of diagnostic and prognostic markers for thyroid cancer: a proteomics approach (Anastasios Sofiadis). Fakultetsopponent: Dagmar Führer-Sekel, Tyskland.
MARS 2010
Kajsa Lundberg
5 mars, immunbiologi/tumörimmunologi, Karolinska institutet, kl 13.00, föreläsningssalen, Cancer Centrum Karolinska, Karolinska universitetssjukhuset, Solna: On immunotherapy against prostate cancer (Kajsa Lundberg). Fakultetsopponent: Per-Thor Straten, Danmark.
Alexander Pietras
12 mars, laboratoriemedicin, ssk molekylär medicin, Lunds universitet, kl 09.00, föreläsningssalen, Patologihuset, Skånes universitetssjukhus, Malmö: Hypoxia-inducible factors in tumor cell differentiation and tumor vascularization (Alexander Pietras). Fakultetsopponent: Randall Johnson, USA.
Caroline Nordenvall
19 mars, cancerepidemiologi, Karolinska institutet, kl 09.15, Petrénsalen, Nobels väg 12B: Aspects of the etiology and survival of lower gastrointestinal cancers (Caroline Nordenvall). Fakultetsopponent: John A Baron, USA.
Christina Swärd
25 mars, kirurgi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Aspects on diagnosis and treatment of gastrointestinal neuroendocrine tumours (Christina Swärd). Fakultetsopponent: Claes Juhlin.
Helena Tassidis
26 mars, laboratoriemedicin, ssk tumörbiologi, Lunds universitet, kl 09.00, MFC, ingång 59, Skånes universitetssjukhus, Malmö: Expression and func-tion of the protein tyrosine phospha-tases SHP-1 and SHP-2 in prostate cancer (Helena Tassidis). Fakultetsopponent: Pernilla Wikström.
Katarina Johansson
26 mars, medicinsk vetenskap, Karolinska institutet, kl 09.00, sal Atrium, Nobels väg 12B: Microsomal glutathione transferase 1 in anti-cancer drug resistance and protection against oxidative stress (Katarina Johansson). Fakultetsopponent: Kenneth Tew, USA.
Björn Widhe
26 mars, ortopedi, Karolinska institutet, kl 09.00, Kugelbergsalen, R1:U1, Karolinska universitetssjukhuset, Solna: Chest wall sarcomas (Björn Widhe). Fakultetsopponent: Hans Hagberg.
Salina Gunnarsson
26 mars, biomedicin, ssk neurokirurgi, Lunds universitet, kl 09.30, Segerfalksalen, Wallenberg Neurocentrum: Synergistic effects of mesenchymal stromal cells and immunotherapy in experimental brain tumors (Salina Gunnarsson). Fakultetsopponent: Karin Forsberg-Nilsson.
Norafiza Zainuddin
31 mars, onkologi, Uppsala universitet, kl 09.00, Auditorium Minus, Akademigatan 3: Molecular genetic analysis in B-cell lymphoma: a focus on the p53 pathway and p16INK4a (Norafiza Zainuddin). Fakultetsopponent: Kirsten Grønbæk, Danmark.
FEBRUARI 2010
Adalsteinn Gunnlaugsson
19 februari, onkologi, Lunds universitet, kl 09.00, föreläsningssalen, Barngatan 2, Universitetssjukhuset i Lund: Chemoradiation in gastrointestinal cancer (Adalsteinn Gunnlaugsson). Fakultetsopponent: Ragnar Hultborn.
Per Byström
26 februari, onkologi, Karolinska in-stitutet, kl 09.30, föreläsningssalen, Radiumhemmet, Karolinska universitetssjukhuset, Solna: Colorectal cancer treatment and early response evaluation, how do we best evaluate treatment response? (Per Byström). Fakultetsopponent: Svein Dueland, Norge.
Géraldine Giraud
26 februari, medicinsk vetenskap, Karolinska institutet, kl 10.00, föreläsningssalen, Cancer Centrum Karolinska: Studies on polyomaviruses in humans in relation to haematopoietic stem cell transplantation and cancer (Géraldine Giraud). Fakultetsopponent: Hans H Hirsch, Schweiz.
Braslav Jovanovic
26 februari, onkologi/experimentell onkologi, Karolinska institutet, kl 09.00, rehabsalen, Norrbacka, Karolinska universitetssjukhuset, Solna: Mutations and molecular signatures in human melanoma (Braslav Jovanovic). Fakultetsopponent: Susana Puig Sarda, Spanien.
JANUARI 2010
Sofia Halin
22 januari, patologi, Umeå universitet, kl 10.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: Targeting the prostate tumor microenvironment and vasculature – the role of castration, tumor-associated macrophages and pigment epithelium-derived factor (PEDF) (Sofia Halin). Fakultetsopponent: Carl-Henrik Heldin.
Sara Mangsbo
29 januari, immunologi, Uppsala universitet, kl 09.15, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Immunological checkpoint blockade and TLR stimulation for improved cancer therapy (Sara Mangsbo). Fakultetsopponent: Rolf Kiessling.
Fang Zong
29 januari, tumörbiologi, Karolinska institutet, kl 09.00, sal 9Q, Alfred Nobels allé 8, Huddinge: Studies on syndecan-1 in mesenchymal tumors (Fang Zong). Fakultetsopponent: Jacob van den Born, Nederländerna.
Andreas Lewander
29 januari, onkologi, Linköpings universitet, kl 09.00, Eken, ingång 65, Universitetssjukhuset i Linköping: Polymorphism and expression of NF-kB in relation to susceptibility and prognosis of colorectal cancer patients (Andreas Lewander). Fakultetsopponent: Bengt Gustavsson.
David Lyrdal
29 januari, urologi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Localized and metastatic renal cell carcinoma aspects on treatment (David Lyrdal). Fakultetsopponent: Börje Ljungberg.
DECEMBER 2009
Lova Perup Segerström
3 december, medicinsk vetenskap, Karolinska institutet, kl 14.30, Lars Leksells auditorium, Eugeniahemmet, T3:02, Karolinska universitetssjukhuset, Solna: Novel experimental target-ed therapy of neuroblastoma (Lova Perup Segerström). Fakultetsopponent: Angelika Eggert, Tyskland.
Nanna Lindberg
4 december, molekylär medicin, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Cellular origin and de-velopment of glioma (Nanna Lindberg). Fakultetsopponent: Kristian Pietras.
Mohit Aggarwal
11 december, medicinsk vetenskap, Karolinska institutet, kl 09.00, föreläsningssal C1:87, Karolinska universitetssjukhuset, Huddinge: Biological pathways in B-cell non-Hodgkin’s lymphoma (Mohit Aggarwal). Fakultetsopponent: Mats Ehinger.
Gustav Nilsonne
11 december, patologi, Karolinska institutet, kl 09.00, sal 9Q Månen, Alfred Nobels allé 8, Huddinge: Experimental therapeutics against malignant meso-thelioma – investigations in vitro (Gustav Nilsonne). Fakultetsopponent: Ben Davidson, Norge.
Marie Fiaschi
17 december, cancerbiologi, Karolinska institutet, kl 10.00, hörsal Månen, Novum, Huddinge: Regulation of hedgehog signalling during development and carcinogenesis (Marie Fiaschi). Fakultetsopponent: Göran Stenman.
Marcus Thomasson
18 december, onkologi, Umeå universitet, kl 09.00, Lionssalen (sal 244), byggnad 7, Norrlands universitetssjukhus: Expression and prognostic value of LRIG1 and the EGF-receptor family in renal cell and prostate cancer (Marcus Thomasson). Fakultetsopponent: Sten Nilsson.
Björn Lövström
18 december, reumatologi, Karolinska institutet, kl 09.00, föreläsningssalen, CMM, Karolinska universitetssjukhuset, Solna: Systemic lupus erythematosus (SLE) and cancer. Epidemiological and immunohistochemical studies on SLE patients with malignant lymphoma or myeloid leukaemia (Björn Lövström). Fakultetsopponent: Elke Theander.
Eric Olm
18 december, medicinsk vetenskap, Karolinska institutet, kl 13.00, sal 9Q, Alfred Nobels allé 8, Huddinge: Cytotoxic mechanisms of selenium in cancer (Eric Olm). Fakultetsopponent: Julian Spallholz, USA.
Anna Gustafsson
18 december, experimentell klinisk kemi, Lunds universitet, kl 09.00, Jubileumsaulan, Universitetssjukhuset MAS, Malmö: A multifaceted study of the receptor tyrosine kinase Axl with focus on renal cell carcinoma (Anna Gustafsson). Fakultetsopponent: Arne Östman.
Nimrod G B Kiss
22 december, medicinsk genetik, Karolinska institutet, kl 10.00, föreläsningssalen, CMM: DNA methylation and gene expression patterns in adrenal medullary tumors (Nimrod G B Kiss). Fakultetsopponent: Peter Söderkvist.
NOVEMBER 2009
Carin Sandberg
6 november, dermatologi och venereologi, Göteborgs universitet, kl 13.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Aspects of fluores-cence diagnostics and photodynamic therapy of non-melanoma skin cancer (Carin Sandberg). Fakultetsopponent: Chris Anderson.
Anders Wittrup
6 november, onkologi, Lunds universitet, kl 09.00, GK-salen, BMC, Sölvegatan 19: Endocytosis of therapeutic macromolecules in tumor cells – mechanistic aspects of the proteoglycan receptor function (Anders Wittrup). Fakultetsopponent: Alain Prochiantz, Frankrike.
Joakim Hennings
14 november, kirurgi, Uppsala universitet, kl 09.15, auditorium Minus, Museum Gustavianum: Clinical studies on adrenocortical tumours using [11C]-metomidate positron emission tomog-raphy (Joakim Hennings). Fakultetsopponent: Bo Wängberg.
Helené Gustavsson
16 november, urologi, Göteborgs universitet, kl 09.00, Hjärtats aula, Sahlgrenska universitetssjukhuset: Androgen-independent prostate cancer – studies on angiogenesis and ADAMTS1 (Helené Gustavsson). Fakultetsopponent: Sven Påhlman.
Kari Nielsen
20 november, dermatologi, Lunds universitet, kl 13.00, Segerfalksalen, hus A, BMC: Malignant melanoma – risk factors and the CDKN2A mutation in relation to phenotypes and other cancers (Kari Nielsen). Fakultetsopponent: Bernt Lindelöf.
Helena Persson
24 november, klinisk medicin, ssk experimentell onkologi, Segerfalksalen, Wallenberg Neurocentrum, BMC, Sölvegatan 17: Small non-coding RNAs in cancer (Helena Persson). Fakultetsopponent: John W M Martens, Nederländerna.
Maria Pernemalm
27 november, medicin, Karolinska institutet, kl 09.30, föreläsningssalen, CCK: Cancer proteomics: Method de-velopment for mass spectrometry bases analysis of clinical materials (Maria Pernemalm). Fakultetsopponent: Tomas Joos, Tyskland.
Christina Persson
27 november, epidemiologi, Karolinska institutet, kl 09.15, hörsalen, MTC, Theorells väg 1: Roles of Helicobacter pylori infection, host genetic variation, and other environment exposures in gastric carcinogenesis (Christina Persson). Fakultetsopponent: Silvia Franceschi, Frankrike.
OKTOBER 2009
Annikki Jonsson
1 oktober, urologi, Göteborgs universitet, kl 13.00, hörsal Arvid Carlsson, Medicinaregatan 3: Prostate cancer and its influence on men’s daily lives (Annikki Jonsson). Fakultetsopponent: Britt-Marie Ternestedt.
Ivan Shabo
2 oktober, kirurgi, Linköpings universitet, kl 13.00, Berzeliussalen, ingång 65, Universitetssjukhuset i Linköping: Macrophage antigen expression in breast and colorectal cancers. A consequence of macrophage–tumour cell fusion? (Ivan Shabo). Fakultetsopponent: Bengt Gustavsson.
Emma Hernlund
9 oktober, medicinsk vetenskap, Karolinska institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska universitetssjukhuset, Solna: Mitochondria and cellular energy metabolism in platinum chemotherapy (Emma Hernlund). Fakultetsopponent: Varda Shoshan-Barmatz, Israel.
Stefanie Prast-Nielsen
9 oktober, medicinsk biokemi, Karo-linska institutet, kl 09.00, Samuelssonsalen, Scheelelaboratoriet, Scheeles väg 2: Exploring thioredoxin reductase as an anticancer drug target (Stefanie Prast-Nielsen). Fakultetsopponent: Dolph Lee Hatfield, USA.
Yuan Xue
9 oktober, tumörbiologi, Karolinska institutet, kl 09.00, hörsalen, MTC, Theorells väg 1: Mechanism of pathological angiogenesis in adipose tissue and tumor (Yuan Xue). Fakultetsopponent: Paul Trayhurn, England.
Ingrid Ljuslinder
16 oktober, onkologi, Umeå universitet, kl 09.00, Lionssalen, byggnad 7, Norrlands universitetssjukhus: Studies of LRIG1 and ERBB receptor family in breast and colorectal cancer (Ingrid Ljuslinder). Fakultetsopponent: Mef Nilbert, Danmark.
Sara Jonmarker Jaraj
16 oktober, medicinsk vetenskap, Karolinska institutet, kl 08.45, föreläsningssalen, CCK: Tissue biomarkers in pros-tate cancer (Sara Jonmarker Jaraj). Fakultetsopponent: Anders Bjartell.
Johan Hansson
23 oktober, onkologi, Uppsala universitet, kl 13.00, Auditorium minus, Gustavianum, Akademigatan 3: Loco-regional treatment of peritoneal carcinomatosis: survival, morbidity and quality of life (Johan Hansson).Fakultetsopponent: Peter Naredi.
SEPTEMBER 2009
Carl Wibom
18 september, onkologi, Umeå universitet, kl 09.00, Lionssalen, byggnad 7, Norrlands universitetssjukhus: Multivariate analyses of proteomic and metabolomic patterns in brain tumours (Carl Wibom). Fakultetsopponent: Janne Lehtiö.
Emma Niméus-Malmström
18 september, onkologi, Lunds universitet, kl 09.00, föreläsningssalen, avd för onkologi, Universitetssjukhuset i Lund: Prognostic and treatment predictive factors for radio- and chemo-
therapy resistance in breast cancer patients – a step towards personlized medicine (Emma Niméus-Malmström). Fakultetsopponent: Ingela Turesson.
Nils Elander
11 september, medicinsk genetik, Linköpings universitet, kl 09.00, Berzeliussalen, ingång 65, Universitetssjuk-huset i Linköping: Inflammation-associated genes and genetic variations in colorectal cancer (Nils Elander). Fakultetsopponent: Mef Nilbert.
JUNI 2009
John Paoli
3 juni, dermatologi och venereologi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Selected aspects on im-proving the management of skin cancer (John Paoli). Fakultetsopponent: Bernt Lindelöf.
Fredrik Qvarnström
3 juni, onkologi, Uppsala universitet, kl 09.15, sal IX, Universitetshuset: DNA damage response of normal epidermis in the clinical setting of fractionated radiotherapy: evidence of a preserved low-dose hypersensitivity response (Fredrik Qvarnström). Fakultetsopponent: Mats Harms-Ringdahl.
Maria Dahlström Wester
4 juni, medicinsk cellbiologi, Linköpings universitet, kl 09.00, aulan, Hälsans hus, Universitetssjukhuset i Linköping: Aspects of tumour targeting. Preclinical studies on human malignant cells in vitro (Maria Dahlström Wester). Fakultetsopponent: Lars Gedda.
Tanja Stocks
5 juni, urologi och andrologi, Umeå universitet, kl 13.15, sal B, 9 tr, Tandläkarhögskolan: Metabolic factors and cancer risk (Tanja Stocks). Fakultetsopponent: Jaap Seidell, Nederländerna.
Karin Jennbacken
5 juni, urologi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Invasive and metastatic properties of advanced pros-tate cancer (Karin Jennbacken). Fakultetsopponent: Pirkko Härkönen.
Darawalee Wangsa
10 juni, medicinsk vetenskap, Karolinska institutet, kl 09.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Molecular profiling for predicting tumor prognosis, treatment outcome and progression of squamous cell carcinoma (Darawalee Wangsa). Fakultetsopponent: Björn Risberg, Norge.
MAJ 2009
Caroline Wigerup
8 maj, patologi, Lunds universitet, kl 09.00, föreläsningssalen, Patologihuset, ingång 78, Universitetssjukhuset MAS, Malmö: Phosphorylation of ERa and HIF-1a in breast cancer with focus on tamoxifen response and links to kinase activation (Caroline Wigerup). Fakultetsopponent: Lesley-Ann Martin, England.
Magdalena Adde
9 maj, onkologi, Uppsala universitet, kl 09.15, Gustavianum, Akademigatan 3: Aggressive B-cell lymphomas: studies of treatment, FDG-PET evaluation and prognostic factors (Magdalena Adde). Fakultetsopponent: Tor Ekman.
Kalle Andreasson
15 maj, experimentell onkologi, Karolinska institutet, kl 09.00, föreläsningssalen, CancerCentrum Karolinska: Vaccination against Her2/neu-express-ing cancer using chimeric virus-like particles (Kalle Andreasson). Fakultetsopponent: Magnus Essand.
Ingrid Glimelius
16 maj, onkologi, Uppsala universitet, kl 09.15, auditorium Minus, Gustavianum, Akademigatan 3: Hodgkin lymphoma – an interplay between tumour cell and microenvironment (Ingrid Glimelius). Fakultetsopponent: Volker Diehl, Tyskland.
Karin Söderlund Leifler
20 maj, onkologi, Linköpings universitet, kl 13.00, Berzeliussalen, ingång 65, Universitetssjukhuset i Linköping: DNA repair pathways and the effect of radiotherapy in breast cancer (Karin Söderlund Leifler). Fakultetsopponent: Bo Stenerlöw.
Ole Forsberg
26 maj, klinisk immunologi, Uppsala universitet, kl 13.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Generation of therapeutic T cells for prostate cancer (Ole Forsberg). Fakultetsopponent: Gustav Gaudernack, Spanien.
Göran Ronquist
27 maj, klinisk kemi, Uppsala universitet, kl 09.15, Rosénsalen, ingång 95, Akademiska sjukhuset: Some characteristics of human prostasomes and their relationship to prostate cancer (Göran Ronquist). Fakultetsopponent: Alicia Llorente, Norge.
Marcus Langenskiöld
28 maj, kirurgi, Göteborgs universitet, kl 13.00, Stora aulan, centralkliniken, Sahlgrenska Universitetssjukhuset/Östra: Tissue remodelling proteases as prognostic factors in colon and r ectal cancer (Marcus Langenskiöld). Fakultetsopponent: Peter Roberts, Finland.
Emilie Friberg
29 maj, medicinsk vetenskap, Karolinska institutet, kl 13.00, Samuelssonsalen, Tomtebodavägen 6: Diet and endometrial cancer. Insulin related factors (Emilie Friberg). Fakultetsopponent: Valerie Beral, England.
Daniella Pfeifer
29 maj, onkologi, Linköpings universitet, kl 09.00, Eken, ingång 65, Universitetssjukhuset i Linköping: p73 in colorectal cancer (Daniella Pfeifer). Fakultetsopponent: Vladimir Bykov.
Lovisa Österberg
29 maj, onkologi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Characterization of genetic alterations in ovarian cancer associated with chemotherapy response (Lovisa Österberg). Fakultetsopponent: Bo Baldetorp.
APRIL 2009
Pia Baumann
24 april, medicinsk vetenskap, Karolinska institutet, kl 09.00, Radiumhemmets föreläsningssal, plan 1, Karolinska Universitetssjukhuset Solna: Stereotactic body radiotherapy in non-small cell lung cancer (Pia Baumann). Fakultetsopponent: Robert Timmerman, USA.
Eva Angenete
24 april, kirurgi, Göteborgs universitet, kl 13.00, Humlen, Servicehuset, Sahlgrenska Universitetssjukhuset/Östra: Remodelling of extracellular matrix in rectal cancer and preoperative radio-therapy (Eva Angenete). Fakultetsopponent: Per-Anders Larsson.
Erik Syk
30 april, kirurgi, Karolinska institutet, kl 09.00, Bringsalen, Erstagatan 1K: Aspects on local recurrence of rectal cancer (Erik Syk). Fakultetsopponent: Sören Laurberg, Danmark.
Annika Wahlström
30 april, medicin, ssk molekylär medicin, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Medicinaregatan 3: Defining RCE1 and ICMT as therapeutic targets in K-RAS-induced cancer (Annika Wahlström). Fakultetsopponent: Channing J Der, USA.
Lili Milani
17 april, molekylär medicin, Uppsala universitet, kl 13.00, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Gene expression in cancer cells: detection of splice variants, allele-specific expression and DNA methylation (Lili Milani). Fakultetsopponent: Thomas R Gingeras, USA.
Marie Ahnström Waltersson
17 april, onkologi, Linköpings universitet, kl 09.00, Linden, ingång 65, Universitetssjukhuset i Linköping: Cell cycle regulators and 11q13 amplification in breast cancer – prediction of adjuvant treatment response (Marie Ahnström Waltersson). Fakultetsopponent: Marie-Louise Fjällskog.
Jakob Eberhard
17 april, klinisk medicin, ssk reproduktion, Lunds universitet, kl 09.00, kvinnoklinikens aula, plan 3, ingång 74, Universitetssjukhuset MAS, Malmö: Testicular cancer: gonadal, sexual and psychological aspects of the disease and its treatment (Jakob Eberhard). Fakultetsopponent: Mikael Rørth, Danmark.
MARS 2009
Emma Ivansson
13 mars, medicinsk genetik, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Contribution of immunogenetic factors in susceptibility to cervical cancer (Emma Ivansson). Fakultetsopponent: Allan Hildesheim, USA.
Amos Rodger Mwakigonja
20 mars, patologi, cytologi, experimentell patologi, Karolinska institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Kaposis’ sarcoma and malignant lymphomas in Tanzania during the aids epidemic (Amos Rodger Mwakigonja). Fakultetsopponent: Michael Dictor.
Martin Almquist
27 mars, kirurgi, Lunds universitet, kl 13.00, aulan, MFC, ingång 59, Universitetssjukhuset MAS, Malmö: Calcium metabolism and breast cancer risk (Martin Almquist). Fakultetsopponent: Jan Frisell.
FEBRUARI 2009
Kristoffer Derwinger
26 februari, kirurgi, Göteborgs universitet, kl 09.00, Stora aulan, centralkliniken, Sahlgrenska Universitetssjukhuset/Östra: Prognostic and predictive facors in colorectal cancer (Kristoffer Derwinger). Fakultetsopponent: Joar Svanvik.
Dieter Fuchs
27 februari, medicinsk cellbiologi, Uppsala universitet, kl 09.15, sal C4:305, BMC, Husargatan 3: Novel treatment modalities for high-risk neuroblastoma: studies in animal models (Dieter Fuchs). Fakultetsopponent: Sven Påhlman.
Chantal Claudine Orgéas
27 februari, epidemiologi, Karolinska institutet, kl 09.00, hörsal Atrium, Nobels väg 12B: Endogenous and exogenous hormonal factors in female cancers – studies of risk and prognosis (Chantal Claudine Orgéas). Fakultetsopponent: Tommy Fornander.
Kristina Levan
27 februari, onkologi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Molecular characterization of type 1 endometrial carcinomas (Kristina Levan). Fakuletsopponent: Stefan Imreh.
JANUARI 2009
Åsa Bolander
16 januari, onkologi, Uppsala universitet, kl 09.15, Skoogsalen, ingång 78, Akademiska sjukhuset: Prognostic factors in malignant melanoma (Åsa Bolander). Fakultetsopponent: Torgny Rasmuson.
Maria Sandström
23 januari, onkologi, Umeå universitet, kl 13.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: Experimental therapies of malignant glioma, with emphasis on angiogenesis inhibition (Maria Sandström). Fakultetsopponent: Anja Smits.
Åsa Odenbro
23 januari, medicinsk vetenskap, Karolinska institutet, kl 09.00, Welandersalen, hudkliniken, plan 00, B2, Karolinska Universitetssjukhuset Solna: Skin cancer in relation to tobacco use and organ transplantation (Åsa Odenbro). Fakultetsopponent: Chris Anderson.
Gabriella Jansson Palmer
30 januari, kirurgi, Karolinska institutet, kl 09.00, Nanna Svartz auditorium, Karolinska Universitetssjukhuset Solna: Locally advanced rectal cancer – aspects on management, outcome and quality of life (Gabriella Jansson Palmer). Fakultetsopponent: Theo Wiggers, Nederländerna.
DECEMBER 2008
Jérémy Lambert
5 december, experimentell onkologi, Karolinska institutet, kl 09.45, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Mutant p53 reactivation by PRIMA-1: molecular mechanism and biological effects (Jérémy Lambert). Fakultetsopponent: Bjørn Tore Gjertsen, Norge.
Andreas Pettersson
5 december, klinisk epidemiologi, Karolinska institutet, kl 09.00, Skandiasalen, Astrid Lindgrens barnsjukhus, Karolinska Universitetssjukhuset Solna: Testicular cancer – new etiological understanding of the epidemic (Andreas Pettersson). Fakultetsopponent: Tom Grotmol, Norge.
Peter Hammarsten
10 december, patologi, Umeå universitet, kl 13.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: Androgen controlled regulatory systems in prostate cancer. Potential new therapeutic targets and prognostic markers (Peter Hammarsten). Fakultetsopponent: Sten Nilsson.
Anna Söderlund Strand
10 december, medicinsk mikrobiologi, Lunds universitet, kl 09.00, patologiska institutionens föreläsningssal, ingång 78, Universitetssjukhuset MAS, Malmö: Human papillomavirus testing and its application in cervical cancer prevention (Anna Söderlund Strand). Fakul-tetsopponent: Ulf Gyllensten.
Tufve Nyholm
12 december, radiofysik, Umeå universitet, kl 09.00, sal 244, byggnad 7, Norrlands universitetssjukhus: Verification of dose calculations in radiotherapy (Tufve Nyholm). Fakultetsopponent: Ben Mijnheer, Nederländerna.
Margaretha Åkeson
12 december, onkologi, Göteborgs universitet, kl 09.00, hörsal Ivan Ivarsson, Medicinaregatan 3A: Clinical outcome and prognostic factors in borderline ovarian tumors and invasive ovarian carcinomas in Western Sweden (Margaretha Åkeson). Fakultetsopponent: Elisabeth Åvall-Lundqvist.
Karolin Hansén Nord
12 december, laboratoriemedicin, ssk experimentell klinisk genetik, Lunds universitet, kl 10.00, föreläsningssal F3, Centralblocket, Universitetssjukhuset i Lund: Array based genetic profiling of bone and soft tissue tumors (Karolin Hansén Nord). Fakultetsopponent: Florence Pedeutour, Frankrike.
Olof Ståhl
12 december, klinisk medicin, ssk reproduktion, Lunds universitet, kl 13.00, Jubileumsaulan, ingång 59, Universitetssjukhuset MAS, Malmö: Cancer and male reproductive function – the effect on sperm DNA integrity and on birth outcomes in the offspring (Olof Ståhl). Fakultetsopponent: Outi Hovatta.
Oscar Persson
13 december, klinisk medicin, ssk neurokirurgi, Lunds universitet, kl 12.30, Segerfalksalen, Wallenberg Neurocentrum: Gene and protein expression in human gliomas (Oscar Persson). Fakultetsopponent: John H Sampson, England.
Daniel Bexell
17 december, neurokirurgi, Lunds universitet, kl 09.15, Segerfalksalen, Wallenberg Neurocentrum: Stem cell based therapy of malignant brain tumors. Mesenchymal and neural precursor cells as migratory vehicles in experimental gliomas (Daniel Bexell). Fakultetsopponent: Bengt Westermark.
NOVEMBER 2008
Andreas Thorstenson
28 november, urologi, Karolinska institutet, kl 09.00, Rolf Lufts auditorium, Karolinska Universitetssjukhuset Solna: On the detection and management of urinary bladder carcinoma (Andreas Thorstenson). Fakultetsopponent: Staffan Jahnson.
Aina Johnsson
14 november, onkologi/experimentell onkologi, Karolinska institutet, kl 13.00, aulan, Södersjukhuset: The rehabilitation process after breast cancer diagnosis. Factors of importance for return to work (Aina Johnsson). Fakultetsopponent: Lars-Olof Persson.
Maryna Mezhybovska
7 november, laboratoriemedicin, ssk cellpatologi, Lunds universitet, kl 13.00, föreläsningssalen, Patologihuset, Universitetssjukhuset MAS, Malmö: LTD4 signalling via beta-catenin: a possible link between inflammation and cancer (Maryna Mezhybovska). Fakultetsopponent: Inke Näthke, Skottland.
OKTOBER 2008
Carin Staland Nyman
24 oktober, socialmedicin, Göteborgs universitet, kl 09.00, hörsal 2118, Arvid Wallgrens Backe 2: Domestic workload and multiple roles. Epidemiological
findings on health and sickness absence in women (Carin Staland Nyman). Fakultetsopponent: Per-Olof Östergren.
Térèse A Johansson
25 oktober, endokrinologi och diabetologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Pancreatic endocrine tumourigenesis: genes of potential importance (Térèse A Johansson). Fakultetsopponent: Martin Bäckdahl.
Anna Birgersdotter
30 oktober, cell- och tumörbiologi, Karolinska institutet, kl 09.30, föreläsningssalen, MTC, Theorells väg 1: Transcriptome based analysis of Hodgkin lymphoma: insights into the microenvironment (Anna Birgersdotter). Fakultetsopponent: Volker Diehl, Tyskland.
Nimesh Bhaskaran
9 oktober, medicinsk vetenskap, Karolinska institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: TGF-beta signaling in carcinogenic transformation of breast epithelial cells, using proteomics (Nimesh Bhaskaran). Fakultetsopponent: Pavel Gromov, Danmark.
Camilla Thellenberg Karlsson
17 oktober, onkologi, Umeå universitet, kl 09.00, sal 244, byggnad 7, Norrlands universitetssjukhus: Prostate cancer – epidemiological studies of risk factors (Camilla Thellenberg Karlsson). Fakultetsopponent: Peter Iversen, Danmark.
Britt-Marie Bernhardson
23 oktober, medicinsk vetenskap, Karolinska institutet, kl 09.00, föreläsningssal 4V, Alfred Nobels allé 8: Smak- och luktförändringar vid cytostatikabehandling (Britt-Marie Bernhardson). Fakultetsopponent: Per-Olof Sandman.
Erika Bågeman
23 oktober, klinisk medicin, ssk onkologi, Lunds universitet, kl 13.00, Segerfalksalen, Wallenberg Neurocentrum: Genetic polymorphisms in breast cancer in relation to risk and prognosis (Erika Bågeman). Fakultetsopponent: Per Hall.
Rona J Strawbridge
24 oktober, patologi, cytologi/experi-mentell patologi, Karolinska institutet, kl 09.00, föreläsningssalen, CancerCentrum Karolinska, R8:00, Karolinska Universitetssjukhuset Solna: Analysis of functional genetic polymorphisms in prostate cancer and type 2 diabetes: Mucin 1 and growth hormone receptor (Rona J Strawbridge). Fakultetsopponent: Paul Pharoah, England.
Cathrine Nilsson
24 oktober, patologi, Linköpings universitet, kl 09.00, Linden, ingång 65, Universitetssjukhuset i Linköping: Impact of lysosomal function in cancer and apoptosis (Cathrine Nilsson). Fakultetsopponent: Emmanuelle Liaudet-Coopman, Frankrike.
David Robinson
24 oktober, kirurgi, ssk urologi, Linköpings universitet, kl 13.00, Originalet, hus B4, Qulturum, Länssjukhuset Ryhov, Jönköping: Prediction of survival in prostate cancer – aspects on localised, locally advanced and metastatic disease (David Robinson). Fakultetsopponent: Börje Ljungberg.
SEPTEMBER 2008
Lisa Sand
15 september, medicinsk vetenskap, Karolinska institutet, kl 13.15, aulan, Stockholms sjukhem, Mariebergsgatan 22: Existential challenges and coping in palliative cancer care (Lisa Sand). Fakultetsopponent: Margareta Östman.
Annette Wigertz
24 september, epidemiologi, Karolinska institutet, kl 09.00, Hillarpsalen, Retzius väg 8: Factors associated with brain tumor risk with focus on female sex hormones and allergic conditions (Annette Wigertz). Fakultetsopponent: Jonas Manjer.
Magdalena Prahl
25 september, onkologi/experimentell onkologi, Karolinska institutet, kl 10.00, föreläsningssalen, R8:04, CCK, Karolinska Universitetssjukhuset Solna: The p53-induced Wig-1 protein: Studies of interaction partners and expression in tumor cells (Magdalena Prahl). Fakultetsopponent: Xiao-Feng Sun.
AUGUSTI 2008
Åsa Wallin
29 augusti, onkologi, Linköpings universitet: Molecular studies of irradiation and SN-38 on colorectal cancer (Åsa Wallin). Fakultetsopponent: Peter Naredi.
Veronica Janson
29 augusti, klinisk kemi, Umeå universitet, kl 09.00, sal 04, byggnad 6E,
Norrlands universitetssjukhus: Cisplatin-resistance and cell death in tumour
cells (Veronica Janson). Fakultetsopponent: Boris Zhivotovsky.
JULI 2008
JUNI 2008
Karolina Wallenborg
5 juni, cell- och molekylärbiologi, Karolinska institutet, kl 09.30, Hillarpsalen, Retzius väg 8: On histone deacetylases in the epigenetic regulation of neural stem and cancer cell fate (Karolina Wallenborg). Fakultetsopponent: Bogi Andersen, USA.
Ulrica Westermark
5 juni, experimentell patologi, Karolinska institutet, kl 09.30, föreläsningssalen, Cancer Center Karolinska, Karolinska Universitetssjukhuset Solna: DNA repair by HDR in experimental tumorigenesis (Ulrica Westermark). Fakultetsopponent: Thomas Helleday.
Karolina Partheen
5 juni, onkologi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: new prognostic markers in stage III serous ovarian adenocarcinomas (Karolina Partheen). Fakultetsopponent: Åke Borg.
MAJ 2008
David Johansson
23 maj, klinisk kemi, Umeå universitet, kl 13.00, sal D, 9 tr, Tandläkarhögskolan: Bacterial toxins for cancer treatment (David Johansson). Fakultetsopponent: Bo Baldetorp.
Erika Lindström
23 maj, medicinsk vetenskap, Karolinska institutet, kl 10.00, sal 9Q Månen, Alfred Nobels allé 8, Huddinge: Mutational analyses of the tumor suppressor gene PATCHED2. Role in non-melanoma skin cancer and nevoid basal cell carcinoma (Erika Lindström). Fakul-tetsopponent: Johan Hansson.
Carina Lundh Hagelin
23 maj, onkologi/experimentell onko-logi, Karolinska institutet, kl 09.30, aulan, Stockholms sjukhem, Mariebergsgatan 22: Fatigue in patients with advanced cancer: aspects of assessment and measurements (Carina Lundh Hagelin). Fakultetsopponent: Ann Langius-Eklöf.
Karin Enell Smith
24 maj, neurokirurgi, Lunds universitet, kl 09.15, Segerfalksalen, Wallenberg Neurocentrum: Immunotherapy against malignant brain tumors – of mice and men (Karin Enell Smith). Fakultetsopponent: Luc Vallières, Kanada.
Håkan Steen
27 maj, neurovetenskap, Uppsala universitet, kl 09.15, sal B42, BMC, Husargatan 3: Novel interactors of X-linked inhibitor of apoptosis protein: expression and effects on tumor cell death (Håkan Steen). Fakultetsopponent: Bertrand Joseph.
Apostolos V Tsolakis
28 maj, internmedicin, Uppsala universitet, kl 09.15, Enghoffsalen, ingång 50, Akademiska sjukhuset: Characterization of endocrine cells and tumours in the stomach (Apostolos V Tsolakis). Fakultetsopponent: Ola Nilsson.
Pontus Berglund
28 maj, patologi, Lunds universitet, kl 13.00, föreläsningssalen, Patologihuset, ingång 78, Universitetssjukhuset MAS, Malmö: Cell cycle perspectives on breast cancer cell behaviour (Pontus Berglund). Fakultetsopponent: Dan Grandér.
Karolina Helczynska
29 maj, molekylär medicin, Lunds universitet, kl 09.15, föreläsningssalen, Patologihuset, Universitetssjukhuset MAS, Malmö: Hypoxia and hypoxia-inducible factors in normal and malignant breast epithelium (Karolina Helczynska). Fakultetsopponent: Gunilla Enblad.
Nina Funa
31 maj, medicin, Uppsala universitet, kl 13.00, auditorium Minus, Gustavianum, Akademigatan 3: The role of Shb in ES cell differentiation, angiogenesis and tumor growth (Nina Funa). Fakultetsopponent: Lars Holmgren.
Niklas Zar
31 maj, kirurgi, Uppsala universitet, kl 13.00, Originalet, Qulturum, hus B4, Länssjukhuset Ryhov, Jönköping: Epidemiological studies of small intestinal tumours (Niklas Zar). Fakultetsopponent: Anders Bergenfelz.
Gabriella Honeth
16 maj, klinisk medicin, ssk onkologi, Lunds universitet, kl 09.00, Segerfalksalen, Wallenberg Neurocentrum, Sölvegatan 17: Stem and progenitor cells in brain and breast malignancies (Gabriella Honeth). Fakultetsopponent: Matthew Smalley, England.
Zoltan Korodi
16 maj, medicinsk mikrobiologi, Lunds universitet, föreläsningssalen, Patologihuset, ingång 78, Universitetssjukhuset MAS, Malmö: Seroepidemiology of sexually transmitted infections in prostate cancer (Zoltan Korodi). Fakultetsopponent: Sigvard Olofsson.
Ylva Almqvist
17 maj, radiologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Tar-geted therapy of colorectal cancer: preclinical evaluation of a radiolabelled antibody (Ylva Almqvist). Fakultetsopponent: Matthew K Robinson, USA.
Cecilia Ahlin
21 maj, onkologi, Uppsala universitet, kl 09.00, Wilandersalen, M-huset, Universitetssjukhuset, Örebro: Cyclin A and cyclin E as prognostic factors in early breast cancer (Cecilia Ahlin). Fakultets-opponent: Göran Landberg.
APRIL 2008
Thomas Asklund
18 april, onkologi, experimentell onkologi, Karolinska institutet, kl 09.30,Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Two novel combination therapies of glioblastoma multiforme from a Cx43 perspective. Studies of in vitro models (Thomas Asklund). Fakultetsopponent: Anja Smits.
Axel Glaessgen
18 april, patologi, cytologi, experimentell patologi, Karolinska institutet, kl 09.30, aulan, Danderyds sjukhus: Markers of differentiation and prognosis in prostate cancer – a morphological and immunohistochemical study (Axel Glaessgen). Fakultetsopponent: Ivo Leuschner, Tyskland.
Erika Nordberg
24 april, biomedicinsk strålningsvetenskap, Uppsala universitet, kl 09.15, Fåhraeussalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: EGFR and HER2 targeting for radionuclide-based imaging and therapy: preclinical studies (Erika Nordberg). Fakultetsopponent: Peter Bernhardt.
Lalle Hammarstedt
25 april, medicinsk vetenskap, Karolins-ka institutet, kl 09.00, föreläsningssalen, ÖNH-kliniken, A3:02, Karolinska Universitetssjukhuset Solna: Tonsillar cancer: incidence, prevalence of HPV and survival (Lalle Hammarstedt). Fakultetsopponent: Björn Zackrisson.
Elin Jerremalm
25 april, experimentell onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Biotransformation of the antineoplastic drug oxaliplatin: importance for effects and side effects (Elin Jerremalm). Fakultetsopponent: Curt Peterson.
Erik Fredlund
28 april, molekylär medicin, Lunds universitet, kl 09.15, föreläsningssalen, Patologihuset, Universitetssjukhuset MAS, Malmö: Hypoxic gene regulation and oncogenic pathways in neuroblastoma (Erik Fredlund). Fakultetsopponent: Rogier Versteeg, Nederländerna.
MARS 2008
Linda Rickardson
7 mars, klinisk farmakologi, Uppsala universitet, kl 13.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: New methods to screen for cancer drugs and to evaluate their mechanism of action (Linda Rickardson). Fakultetsopponent: Kjell Grankvist.
Irina Radulescu
14 mars, medicinsk strålningsbiologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Induction and repair of DNA double-strand breaks in human cell exposed to different radiation qualities (Irina Radulescu). Fakultetsopponent: Mats Harms-Ringdahl.
Anna Johansson
28 mars, patologi, Umeå universitet, kl 09.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: Angiopoietins in normal and malignant prostate (Anna Johansson). Fakultetsopponent: Arne Östman.
David Lindquist
28 mars, onkologi/experimentell onkologi, Karolinska institutet, kl 09.00, föreläsningssalen, CancerCentrum Karolinska, R8:00, Karolinska Universitetssjukhuset Solna: Studies on the occurrence and effects of human papillomavirus in tumors of the head and neck (David Lindquist). Fakultetsopponent: Sonia Andersson.
Cheng Liu
28 mars, medicinsk vetenskap, Karo-linska institutet, kl 09.00, föreläsningssalen, CMM, L8:00, Karolinska Universitetssjukhuset Solna: Human 15-
lipoxygenase-1 and telomerase gene expression in cancer and inflammation (Cheng Liu). Fakultetsopponent: Dieter Steinhilber, Tyskland.
FEBRUARI 2008
Anneli Karlsson
15 februari, medicinsk cellbiologi, ssk medicinsk genetik, Linköpings universitet, kl 09.00, Berzeliussalen, ingång 65, Universitetssjukhuset i Linköping: Genetic alterations in lymphoma – with focus on the Ikaros, Notch1 and BCL11B genes (Anneli Karlsson). Fakultetsopponent: Dan Grandér.
Jonas Sjölund
15 februari, molekylär medicin, Lunds universitet, kl 09.15, föreläsningssalen, avd för patologi, Universitetssjukhuset MAS, Malmö: Notch signaling in neuroblastoma and renal cell carcinoma (Jonas Sjölund). Fakultetsopponent: Charles G Eberhard, USA.
Linda Boldrup
22 februari, patologi, Umeå universitet, kl 09.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: The role of p63 and p63 related proteins in squamous cell carcinoma of the head and neck (Linda Boldrup). Fakultetsopponent: Wendy Weinberg, USA.
Sofia Vikman
22 februari, klinisk immunologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Towards immunotherapy of midgut carcinoid tumors (Sofia Vikman). Fakultetsopponent: Bengt Widegren.
Patiyan Andersson
29 februari, medicinsk cellbiologi, ssk medicinsk genetik, Linköpings universitet, kl 09.00, Berzeliussalen, ingång 65, Universitetssjukhuset i Linköping: Molecular genetic studies on prostate and penile cancer (Patiyan Andersson). Fakultetsopponent: Mattias Höglund.
Ylva Stewénius
29 februari, klinisk genetik, Lunds universitet, kl 10.00, Segerfalksalen, BMC: Mechanisms and consequences of chromosomal instability in malignant tumours (Ylva Stewénius). Fakultetsopponent: Kathy Pritchard-Jones, England.
JANUARI 2008
Mira Ernkvist
18 januari, onkologi och experimentell onkologi, Karolinska institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Controlling angiogenesis – functional studies of angiomotin (Mira Ernkvist). Fakultetsopponent: Anne Eichmann, Frankrike.
Björn Strander
18 januari, obstetrik och gynekologi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Cervical cancer prevention. Studies on possible improvements (Björn Strander). Fakultetsopponent: Ole-Erik Iversen, Norge.
Christian Hansen
25 januari, experimentell patologi, Lunds universitet, kl 09.15, föreläsningssalen, ingång 78, Universitetssjukhuset MAS, Malmö: Role of DARPP-32 in breast cancer cell signalling and migration (Christian Hansen). Fakultets-opponent: Per Svenningsson.
DECEMBER 2007
Ulrika Rolén
7 december, cell- och tumörbiologi, Karolinska institutet, kl 09.30, föreläsningssal Atrium, Nobels väg 12B: Modulation of the deubiquitinating system in viral infection, lymphoid cell activation and malignant transformation (Ulrika Rolén). Fakultetsopponent: Ivan Dikic, Tyskland.
Kaarina Sundelin
7 december, öron-, näs- och halssjukdomar, Linköpings universitet, kl 13.00, Elsa Brändströmsalen, Universitetssjukhuset i Linköping: Head and neck cancer – factors affecting tumour growth (Kaarina Sundelin). Fakultets-opponent: Hans Gustafsson.
Ingela Berrum Svennung
7 december, urologi, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Carcinoma of the urinary bladder. Aspects on treatment, costs and follow-up routines (Ingela Berrum Svennung). Fakultetsopponent: Hans Wijkström.
Wanzhong Wang
13 december, urologi, Göteborgs universitet, kl 13.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Inflammation and prostatic carcinogenesis – a morphological study of the human prostate (Wanzhong Wang). Fakultetsopponent: Anders Bjartell.
Per Marits
14 december, molekylär medicin, Uppsala universitet, kl 09.15, sal X, Universitetshuset: on CD4+ T lymphocytes in solid tumours (Per Marits). Fakultetsopponent: Alex Karlsson-Parra.
Evangelos Chandanos
14 december, kirurgi, Karolinska institutet, kl 10.00, Welandersalen, B2:01, Karolinska Universitetssjukhuset Solna: Estrogen in the development of esophageal and gastric adenocarcinoma (Evangelos Chandanos). Fakultetsopponent: Lars-Erik Hansson.
Jacob Ehnfors
14 december, onkologi/experimentell onkologi, Karolinska institutet, kl 09.30, föreläsningssalen, Cancer Centrum Karolinska, Karolinska Universitetssjukhuset Solna: On the mechanisms and consequences of cell to cell DNA transfer (Jacob Ehnfors). Fakultetsopponent: Rolf Bjerkvig, Norge.
Anthony S Gunnell
14 december, epidemiologi, Karolinska institutet, kl 09.15, hörsal Atrium, Nobels väg 12B: Risk factors for cervical cancer development (Anthony S Gunnell). Fakultetsopponent: Silvia de Sanjosé, Spanien.
Jia Jing Lee
14 december, medicinsk vetenskap, Karolinska institutet, kl 09.15, Leksellsalen, T3:00, Karolinska Universitetssjukhuset Solna: Behind the scenes of thyroid tumors – underlying genetic mechanisms (Jia Jing Lee). Fakultetsopponent: Håkan Ahlman.
Jessica Svärd
19 december, cancerbiologi, Karolinska institutet, kl 10.00, föreläsningssal 4U Solen, Alfred Nobels allé 8, Huddinge: Repressing the hedgehog signalling pathway. Functional analysis of the tumour suppressors Patched1 and sup-pressor of fused (Jessica Svärd). Fakultetsopponent: Maikel Peppelenbosch, Nederländerna.
Kristian Wennmalm
19 december, medicinsk vetenskap, Karolinska institutet, kl 09.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Analytical strategies for identifying relevant phenotypes in microarray data (Kristian Wennmalm). Fakultetsopponent: Joakim Lundeberg.
Anders Lidgren
21 december, urologi, Umeå universitet, kl 09.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: Expression of hypoxia inducible factor 1a (HIF-1a) in human renal cell carcinoma (Anders Lidgren). Fakultetsopponent: Ulf Bergerheim.
NOVEMBER 2007
Zahra Taheri-Kadkhoda
2 november, onkologi, Göteborgs universitet, kl 09.00, Jubileumsklinikens aula, Sahlgrenska Universitetssjukhuset: Nasopharyngeal carcinoma: past, present and future directions (Zahra Taheri-Kadkhoda). Fakultetsopponent: Cai Grau, Danmark.
Annika Bylund
9 november, urologi, Umeå universitet, kl 09.00, sal 1, byggnad 10, Norrlands universitetssjukhus: Prostatacancer och fytoöstrogener – experimentella, kliniska och epidemiologiska studier (Annika Bylund). Fakultetsopponent: Swen-Olof Andersson.
Marie Oscarsson
9 november, genus och medicin, Linköpings universitet, kl 09.00, aulan, Hälsans hus, Universitetssjukhuset i Linköping: Healthy women or risk patients? Non-attendance in a cervical cancer screening program (Marie Oscarsson). Fakultetsopponent: Eva Johansson.
Camilla Fröjd
9 november, vårdvetenskap, Uppsala universitet, kl 13.15, Skoogsalen, onkologiska kliniken, ingång 78, Akademiska sjukhuset: Cancer patients’ satisfaction with doctors’ care: consequences and contributing conditions (Camilla Fröjd). Fakultetsopponent: Peter Strang.
Susanne Malander
16 november, onkologi, Lunds universitet, kl 13.00, föreläsningssalen, Barngatan 2, Universitetssjukhuset i Lund: Hereditary ovarian cancer: mutation frequencies and genetic profiles (Susanne Malander). Fakultetsopponent: Anne Dørum, Norge.
Amir Reza Razavi
22 november, medicinsk informatik, Linköpings universitet, kl 09.00, Elsa Brändströmsalen, Universitetssjukhuset i Linköping: Applications of knowledge discovery in quality registries – predicting recurrence of breast cancer and analyzing non-compliance with a clinical guideline (Amir Reza Razavi). Fakultetsopponent: Arie Hasman, Nederländerna.
Farhood Iranparvar Alamdari
23 november, urologi, Umeå universitet, kl 13.00, sal E04, byggnad 6E, Norrlands universitetssjukhus: Renal cell carcinoma – factors of importance for follow-up and survival (Farhood Iranparvar Alamdari). Fakultetsopponent: Sven Lundstam.
Ali Khatami
23 november, urologi, Göteborgs universitet, kl 13.00, aulan, Sahlgrenska Universitetssjukhuset: Early prostate cancer. On prognostic markers and predictors of outcome after radical prostatectomy (Ali Khatami). Fakultetsopponent: Mikael Häggman.
Mikael Hanson
23 november, immunbiologi, Karolinska institutet, kl 09.00, föreläsningssalen, Cancer Centrum Karolinska, Karolinska Universitetssjukhuset Solna: Tumor-induced immune dysfunction: mechanism and therapeutic strategies (Mikael Hanson). Fakultetsopponent: Augusto Ochoa, USA.
Ann Rosendahl
23 november, klinisk medicin, ssk onkologi, Lunds universitet, kl 13.00, Segerfalksalen, Wallenberg Neurocentrum: Insulin-like growth factor system: functional role and regulation in carcinoma (Ann Rosendahl). Fakultetsopponent: Michael Pollak, Kanada.
Annette Säfholm
23 november, experimentell patologi, Lunds universitet, kl 09.15, föreläsningssalen, ingång 78, Universitetssjukhuset MAS, Malmö: Wnt-5a signaling in breast cancer metastasis (Annette Säfholm). Fakultetsopponent: Randall Moon, USA.
Marta Röing
29 november, käkkirurgi, Uppsala universitet, kl 13.15, Fåhraeussalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Understanding oral cancer – a lifeworld approach (Marta Röing). Fakultetsopponent: Peter Strang.
Johan Linderoth
29 november, onkologi, Lunds universitet, kl 09.00, föreläsningssalen, Barngatan 2, Universitetssjukhuset i Lund: Diffuse large B-cell lymphoma – tumour characteristics on RNA and protein level associated with prognosis (Johan Linderoth). Fakultetsopponent: Kirsten Grønbæk, Danmark).
Malin Wickström
30 november, klinisk farmakologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Preclinical studies of the melphalan prodrug J1 for cancer therapy (Malin Wickström). Fakultetsopponent: Johan Hansson.
Gustaf Vahlne
30 november, immunologi, Karolinska institutet, kl 13.00, Atrium, Nobels väg 12B: Natural killer cell inhibitory and activating receptors – regulatory role in effector functions against normal and tumor cells (Gustaf Vahlne). Fakultetsopponent: John Torgils Vaage, Norge.
Nicole Zache
30 november, onkologi/experimentell onkologi, Karolinska institutet, kl 09.00, Cancer Center Karolinska, R8:00, Karolinska Universitetssjukhuset Solna: Studies of mutant p53-targeting small molecules (Nicole Zache). Fakultetsopponent: Toivo Maimets, Estland.
Magnus Falk
30 november, dermatologi och venereologi, Linköpings universitet, kl 09.00, aulan, Hälsans hus, Universitetssjukhuset i Linköping: Towards a broader use of phototesting – in research, clinical practice and skin cancer prevention (Magnus Falk). Fakultetsopponent: Olle Larkö.
OKTOBER 2007
Janos Geli
5 oktober, medicinsk vetenskap, ssk molekylär cancergenetik, Karolinska institutet, kl 13.00, föreläsningssalen, CMM, L8:00, Karolinska
Universitetssjukhuset Solna: Further delineation of molecular alterations in adreno-medullary tumors (Janos Geli). Fakultetsopponent: Sven Påhlman.
Mikael Hartman
12 oktober, epidemiologi, Karolinska institutet, kl 09.15, Petrénsalen, Nobels väg 12A: Risk and prognosis of breast cancer among women at high risk of the disease (Mikael Hartman). Fakultetsopponent: Flora Van Leeuwen, Nederländerna.
Fredrik Persson
19 oktober, patologi, Göteborgs universitet, kl 09.00, föreläsningssalen, patologen, Sahlgrenska Universitetssjukhuset: Studies of fusion oncogenes and genomic imbalances in human tumors (Fredrik Persson). Fakultetsopponent: Thoas Fioretos.
SEPTEMBER 2007
Janet Lynn Cunningham
1 september, medicin, Uppsala universitet, kl 09.30, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Tumour biological factors charac-terizing metastasizing serotonin-pro-ducing ileocaecal carcinoids (Janet Lynn Cunningham). Fakultetsopponent: Irvin Modlin, USA.
Mario A Economou
7 september, oftalmologi, Karolinska institutet, kl 09.00, aulan, S:t Eriks ögonsjukhus: Uveal melanoma and macular degeneration: Molecular biol-ogy and potential therapeutic applications (Mario A Economou). Fakultetsopponent: William Harbour, USA.
Malihe Eskandarpour
14 september, onkologi/experimentell onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Molecular genetic of cutaneous malignant melanoma (Malihe Eskandarpour). Fakultetsopponent: Åke Borg.
Barbara Wegiel
11 september, klinisk medicin, ssk urologi, Lunds universitet: Cellular pathways in angiogenesis and tumor cell invasion in prostate cancer (Barbara Wegiel). Fakultetsopponent: Jiri Bartek, Danmark.
Johanna Sandlund
19 september, onkologi, Umeå universitet, kl 09.00, Lionsalen, onkologiska kliniken, Norrlands universitetssjukhus: Angiogenesis in human renal cell carcinoma – hypoxia, vascularity and prognosis (Johanna Sandlund). Fakultetsopponent: Elisabeth Kjellén.
Olav Lindqvist
20 september, onkologi/omvårdnad, Umeå universitet, kl 09.00, Lionsalen, onkologiska kliniken, Norrlands universitetssjukhus: Att leva med kroppsliga förändringar vid obotlig cancersjukdom med fokus på prostatacancer: »Jag är frisk – bortsett från att jag har cancer som är dödlig, men det är liksom en annan sak« (Olav Lindqvist). Fakultetsopponent: Carol Tishelman.
Sara Lindström
20 september, onkologi, Umeå universitet, kl 13.00, sal Betula, byggnad 6M: Genetic variation and prostate cancer (Sara Lindström). Fakultetsopponent: John A Todd, England.
JUNI 2007
Jana de Boniface
1 juni, kirurgi, Uppsala universitet, kl 13.15, aulan, ingång 21, Centrallasarettet Västerås: Sentinel node biopsy in breast cancer: clinical and immunological aspects (Jana de Boniface). Fakultetsopponent: Omgo Nieweg, Nederländerna.
Martin Tondels
4 juni, yrkes- och miljömedicin, Linköpings universitet, kl 09.00, aulan, Hälsans hus, Universitetssjukhuset i Linköping: Malignancies in Sweden after the Chernobyl accident in 1986 (Martin Tondels). Fakultetsopponent: Bengt Järvholm.
Ulrika Nilsson
5 juni, onkologi, Linköpings universitet, kl 09.00, Berzeliussalen, ingång 65, Universitetssjukhuset i Linköping: Effects of sex steroids and tamoxifen on matrix metalloproteinase activity and generation of endostatin in the breast (Ulrika Nilsson). Fakultetsopponent: Lena
Claesson-Welsh.
Henrik Bergquist
1 juni, öron- näs- och halssjukdomar, Göteborgs universitet: Aspects on the management of patients with esophageal cancer (Henrik Bergquist). Fakultetsopponent: Göran Laurell.
Rubaiyat Rahman-Roblick
7 juni, onkologi/experimentell onkologi, Karolinska institutet, kl 13.30, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: The p53 pathway: Role of telomerase and identification of novel targets. Acts of a master regulator and tumor suppression (Rubaiyat Rahman-Roblick). Fakultetsopponent: Ygal Haupt, Israel.
W David Culp
8 juni, onkologi/experimentell onko-logi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Identifying molecular targets for cancer therapy (W David Culp). Fakultetsopponent: Robert C Rees, England.
Helena Stensman
8 juni, molekylär medicin, Lunds universitet, kl 13.00, patologihuset, Universitetssjukhuset MAS, Malmö: Regulation of PKC alpha and the role of PKC in neuroblastoma cell migration (Helena Stensman). Fakultetsopponent: Staffan Johansson.
Katarina Engström
11 juni, onkologi, Göteborgs universitet, kl 13.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Clinical and molecular studies of liposarcoma (Katarina Engström). Fakultetsopponent: Carl Blomqvist.
Mathias Lidgren
12 juni, medicinsk lednings-, organisations- och innovationskunskap, Karolinska institutet, kl 09.00, Hillarpsalen, Retzius väg 8: Health economics of breast cancer (Mathias Lidgren). Fakultetsopponent: Milton Weinstein, USA.
Anna De Geer
14 juni, immunbiologi/tumörimmuno-logi, Karolinska institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Neuroblastoma as a target for effector mechanisms of the immune system (Anna De Geer). Fakultetsopponent: Viktor Umansky, Tyskland.
Pontus Nauclér
14 juni, laboratoriemedicin, ssk medicinsk mikrobiologi, Lunds universitet, kl 13.00, patologens föreläsningssal, Universitetssjukhuset MAS, Malmö: Targeting the human papillomavirus for prevention of cervical cancer (Pontus Nauclér). Fakultetsopponent: Julian Peto, England.
Mona Karlsson
15 juni, klinisk immunologi, allergi, transfusionsmedicin, Karolinska institutet, kl 09.00, Samuelssonsalen, Tomtebodavägen 6: Sentinel node based immuno-therapy of cancer (Mona Karlsson). Fakultetsopponent: Mark Dudley, USA.
Jakob Lagergren
15 juni, plastikkirurgi, Karolinska institutet, kl 10.00, Nanna Svartz auditorium, A1:00, Karolinska Universitetssjukhuset Solna: Immediate breast reconstruction with implants in breast cancer patients. Aspects of surgical technique, quality of life and sensibility (Jakob Lagergren). Fakultetsopponent: Hans Holmström.
Tobias Löfstedt
15 juni, molekylär medicin, Lunds universitet, kl 08.30, patologens föreläsningssal, Universitetssjukhuset MAS, Malmö: Transcriptional regulation by hypoxia-inducible factors in tumor cells (Tobias Löfstedt). Fakultetsopponent: Amato Giaccia, USA.
MAJ 2007
Helena Dzojic
4 maj, klinisk immunologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Adenovirus-mediated CD40 ligand immunotherapy of prostate and bladder cancer (Helena Dzojic). Fakultetsopponent: Aristides Eliopoulos, Grekland.
Maria Berndtsson
4 maj, experimentell onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: On the role of different signal transduction pathways in induction of apoptosis by anticancer drugs (Maria Berndtsson). Fakultetsopponent: Marie-France Poupoun, Frankrike.
Akter Hossain
10 maj, medicinsk cellbiologi, Linköpings universitet, kl 09.00, Linden, ingång 65, Universitetssjukhuset i Linköping: Studies on redox-proteins and cytokines in inflammation and cancer (Akter Hossain). Fakultetsopponent: Christer Lindqvist, Finland.
Jan Lindberg
11 maj, kirurgi, Umeå universitet, kl 09.00, hörsal B, 9 tr, byggnad 1D, Tandläkarhögskolan: Ulcerative colitis – colorectal cancer risk and surveillance in an unselected population (Jan Lindberg). Fakultetsopponent: Curt Tysk.
Josefin Fernebro
24 maj, klinisk medicin, ssk onkologi, Lunds universitet: Soft tissue sarcoma patterns: multiplicity, heterogeneity and growth characteristics (Josefin Fernebro). Fakultetsopponent: Øyvind Bruland, Norge.
Daniel Hägerstrand
25 maj, onkologi/experimentell onko-logi, Karolinska institutet: Molecular determinants of glioma subsets with distinct histology or sensitivity to signal transduction inhibitors (Daniel Hägerstrand). Fakultetsopponent: Jeffrey Settleman, USA.
Princy Francis
25 maj, experimentell onkologi, Lunds universitet: Genetic profiling in soft tissue sarcoma (Princy Francis). Fakultetsopponent: Olle Larsson.
Maria Stendahl
25 maj, patologi, Lunds universitet: Predictive markers for tamoxifen response in primary breast cancer (Maria Stendahl). Fakultetsopponent: Leonie Young, Irland.
APRIL 2007
Linn Hjortsberg
27 april, experimentell onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: On the pro-apoptotic signaling induced by interferon-alpha (Linn Hjortsberg). Fakultets-opponent: Thomas Decker, Österrike.
Staffan Lundström
27 april, onkologi/experimentell onkologi, Karolinska institutet, kl 09.00, aulan, Stockholms sjukhem: Corticosteroids in advanced cancer: epidemiology, symptom relief and patient experiences (Staffan Lundström). Fakultetsopponent: Peter Daneryd.
MARS 2007
Henrik Gréen
2 mars, klinisk farmakologi, Linköpings universitet, kl 13.00, Berzeliussalen, ingång 65, Universitetssjukhuset i Linköping: Pharmacogenetic studies of paclitaxel in ovarian cancer – focus on interindividual differences in pharmacodynamics and pharmacokinetics (Henrik Gréen). Fakultetsopponent: Håkan Melhus.
David Ulmert
10 mars, laboratoriemedicin, ssk klinisk kemi, Lunds universitet, kl 09.15, aulan, CRC, ingång 72, Universitetssjukhuset MAS, Malmö: Assessments of PSA forms and hK2 as very early predictors of prostate cancer (David Ulmert). Fakultetsopponent: Freddie C Hamdy, England.
Amir Osman Abdalla
15 mars, onkologi/experimentell onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Immunological and clinical long-term effects of idiotype vaccination in multiple myeloma patients (Amir Osman Abdalla). Fakultetsopponent: Massimo Massaia, Italien.
Britta Andersson
16 mars, klinisk kemi, Umeå universitet, kl 09.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: Manipulation of potassium ion fluxes to induce apoptosis in lung cancer cells (Britta Andersson). Fakultetsopponent: Ola Brodin.
Michael Hedenus
16 mars, onkologi, Umeå universitet, kl 13.00, Lionssalen JK, byggnad 7, Norrlands universitetssjukhus: Clinical impact of epoetins in the treatment of anemia in patients with lymphoid malignancies: dosing, iron supplementation and safety (Michael Hedenus). Fakultetsopponent: Robert Hast.
Göran Sahlén
16 mars, urologi, Uppsala universitet, kl 13.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Formation, storage and secretion of prostasomes in benign and malignant cells and their immunogenicity in prostate cancer patients (Göran Sahlén). Fakultets-opponent: Anders Bjartell.
Daniel Lindberg
23 mars, kirurgi, Uppsala universitet, kl 13.00, Rosénsalen, kvinnokliniken, ingång 95, Akademiska sjukhuset: Molecular genetic studies of sporadic and MEN1-associated endocrine pancreatic tumors (Daniel Lindberg). Fakultetsopponent: Bo Wängberg.
Annika Sjövall
23 mars, kirurgi, Karolinska institutet, kl 09.00, Nanna Svartz auditorium, Karolinska Universitetssjukhuset Solna: Colon cancer: Management and out-come in a Swedish population (Annika Sjövall). Fakultetsopponent: Sören Laurberg, Danmark.
FEBRUARI 2007
Ioannis Rouvelas
9 februari, kirurgi, Karolinska institutet, kl 10.00, Nanna Svartz
auditorium, huvudentrén, A1:00, Karolinska Universitetssjukhuset
Solna: Esophageal cancer surgery – factors influencing survival
(Ioannis Rouvelas). Fakultetsopponent: Jane Blazeby, England.
Somali Sanyal
9 februari, experimentell onkologi, Karolinska institutet, kl 10.00,
föreläsningssalen, Radiumhemmet, Karolinska Universitetssjukhuset
Solna: Effect of genetic polymorphisms on urinary bladder neoplasms
(Somali Sanyal). Fakultetsopponent: Guido Sauter, Tyskland.
Roy Ehrnström
9 februari, patologi, Lunds universitet, kl 09.00, patologiska
institutionens föreläsningssal, ingång 78, Universitetssjukhuset
MAS, Malmö: Carbonate ions and gastric cancer (Roy Ehrnström).
Fakultetsopponent: Lars Lundell.
Kristjana Einarsdóttir
16 februari, epidemiologi, Karolinska institutet, kl 09.15, hörsal
Petrén, Nobels väg 12B: Genetic determinants of postmenopausal
breast and endometrial cancer (Kristjana Einarsdóttir).
Fakultetsopponent: Heather Spencer Feigelson, USA.
Minghui Liu
21 februari, internmedicin, Uppsala universitet, kl 13.15,
Rosénsalen, ingång 95/96, Akademiska sjukhuset: Gene
therapy with interferon alpha and the angiogenic inhibitor,
vasostatin, in neuroendocrine tumors of the digestive system
(Minghui Liu). Fakultetsopponent: Bertram Wiedenmann, Tyskland.
Niklas Thurfjell
23 februari, patologi, Umeå universitet, kl 09.00, sal E04, byggnad
6E, Norrlands universitetssjukhus: p63 – from expression to
function. Studies of normal oral mucosa and squamous cell carcinoma
of the head and neck (Niklas Thurfjell). Fakultetsopponent: Luisa
Guerrini, Italien.
Kenneth Villman
23 februari, onkologi, Uppsala universitet, kl 13.15, Wilandersalen,
M-huset, Universitetssjukhuset, Örebro: Chemosensitivity in breast
cancer (Kenneth Villman). Fakultetsopponent: Nils Wilking.
Johanna Skoglund
23 februari, medicinsk genetik, Karolinska institutet, kl 09.00,
Rolf Lufts auditorium, L1:00, Karolinska Universitetssjukhuset
Solna: Genetic studies of colorectal cancer (Johanna Skoglund).
Fakultetsopponent: Holger Luthman.
JANUARI 2007
Anna Therése Helén Hemström
26 januari, toxikologi, Karolinska institutet, kl 09.00, sal
Rockefeller, Nobels väg 11: Apoptosis, cellular division or mitotic
catastrophe? Effects of kinase in-hibition and DNA damage in lung
cancer cells (Anna Therése Helén Hemström). Fakultetsopponent: Mauro
Piacentini, Italien.
Linda Strandberg Ihrlund
26 januari, onkologi, Karolinska institutet, kl 10.00, Radiumhemmets
föreläsningssal, Karolinska Universitetssjukhuset Solna:
Cisplatin- induced tumor cell death signaling and potentiation by
energy metabolism inhibitors (Linda Strandberg Ihrlund).
Fakultetsopponent: Jan-Ingvar Jönsson.
Britta Halvarsson
26 januari, patologi, Lunds universitet, kl 13.00, Medicinhistoriska
museet, Bergaliden 20, Helsingborg: Morphological features and
mismatch repair in colorectal tumors (Britta Halvarsson).
Fakultetsopponent: Richard Palmqvist.
Karin Staflin
12 januari, neurobiologi, Lunds universitet: Neural progenitor cells in
malignancy and injury of the brain. A Trojan horse for gliomas? (Karin Staflin).
Fakultetsopponent: Maeve Caldwell, England.
DECEMBER 2006
Martin Sundelöf
1 december, kirurgi, Karolinska institutet, kl 09.00, aulan, Danderyds sjukhus: Aspects on prognosis of cancers of the oesophagus and gastric cardia (Martin Sundelöf). Fakultetsopponent: Bruno Walther.
Hong Xu
1 december, experimentell medicin, Karolinska institutet, kl 09.30, föreläsningssal M63, Karolinska Universitetssjukhuset Huddinge: The role of TPPII in apoptosis control and treatment of malignant disease (Hong Xu). Fakultetsopponent: Lars Rönnstrand.
Karin Karlsson
2 december, biomedicinsk strålningsvetenskap, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Role of non-homologous end-joining in repair of radiation-induced DNA double-strand breaks (Karin Karlsson). Fakultetsopponent: Thomas Helleday.
Thomas Wahlgren
8 december, onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: High dose rate brachytherapy boost for localized prostate cancer: Clinical and patient-reported outcomes (Thomas Wahlgren). Fakultetsopponent: Anders Widmark.
Reiko Suzuki
12 december, epidemiologi, Karolinska institutet: Hormone-related dietary factors and estrogen/progesterone-receptor defined postmenopausal breast cancer (Reiko Suzuki). Fakultetsopponent: Tim Key, England.
Susanna C Larsson
14 december, epidemiologi, Karolinska institutet, kl 10.45, Hillarpsalen, Retzius väg 8: Diet and gastrointestinal cancer: one-carbon metabolism and other aspects (Susanna C Larsson). Fakultetsopponent: Tim Byers, USA.
Di Sun
14 december, cell- och tumörbiologi, Karolinska institutet, kl 13.00, föreläsningssalen, MTC, Theorells väg 1: Epigenetics in nasopharyngeal carcinoma (Di Sun). Fakultetsopponent: Albertina De Sario, Frankrike.
Marika Nestor
15 december, öron-, näs- och halssjukdomar, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Antibody-based radionuclide targeting for diag-nostics and therapy: Preclinical studies on head and neck cancer (Marika Nestor). Fakultetsopponent: Matthew Robinson, USA.
Hao Mo
15 december, tumörbiologi, Karolinska institutet, kl 09.30, föreläsningssalen, MTC, Theorells väg 1: Targeting of the Myc pathway as a novel approach for cancer therapy (Hao Mo). Fakultetsopponent: Thierry Soussi, Frankrike.
NOVEMBER 2006
Tatjana Djureinovic
3 november, medicinsk vetenskap, Karolinska institutet, kl 09.00, Rolf Lufts auditorium, L1:00, Karolinska Universitetssjukhuset Solna: Investigation of genetic factors involved in colorectal cancer predisposition (Tatjana Djureinovic). Fakultetsopponent: Dan Holmberg.
Pia Karlsson
3 november, dermatologi och venereo-logi, Linköpings universitet, kl 09.00, Eken, ingång 65, Universitetssjukhuset i Linköping: Cutaneous melanoma in children and adolescents and aspects of naevus phenotype in melanoma risk assessment (Pia Karlsson). Fakultetsopponent: Johan Hansson.
Thomas Jiborn
3 november, urologi, Lunds universitet, kl 09.15, Jubileumsaulan, Medicinskt forskningscentrum, ingång 59, Universitetssjukhuset MAS, Malmö: Cystatin C and neuroendocrine differentiation in the male reproductive system and in prostate cancer (Thomas Jiborn). Fakultetsopponent: Nils Brunner, Danmark.
Oliver Hedestig
10 november, onkologi, Umeå universitet, kl 09.00, sal Betula, byggnad 6M, Norrlands universitetssjukhus: Att leva med lokaliserad prostatacancer – »oss män emellan« (Oliver Hedestig). Fakultetsopponent: Carina Berterö.
Fredrik Johansson
10 november, patologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Screening for candidate brain tumor genes: Identifying genes that cooperate with platelet-derived growth factor in glioma development and progression (Fredrik Johansson). Fakultetsopponent: Leif Carlsson.
Emma Tham
17 november, medicinsk genetik, Karolinska institutet, kl 13.15, Rolf Lufts auditorium, L1:00, Karolinska Universitetssjukhuset Solna: From gene mutation to gene expression: Studies on multiple endocrine neoplasia type 1 and vascular endothelial growth factors (Emma Tham). Fakultetsopponent: Margareta Nordling.
Johan Johansson
24 november, epidemiologi, Karolinska institutet, kl 09.00, föreläsningssal Atrium, Nobels väg 12B: Barrett’s oesophagus and metaplasia at the oesophagogastric junction: An epidemiological approach (Johan Johansson). Fakultetsopponent: Liam Murray, Nordirland.
OKTOBER 2006
Daria Cosaceanu
6 oktober, medicinsk strålningsbiologi, Karolinska institutet, kl 10.00, föreläsningssalen, Radiumhemmet, Karolinska Universitetssjukhuset Solna: The use of IGF-IR inhibitors in cancer therapy – a potential approach for sensitizing tumor cells to ionizing radiation (Daria Cosaceanu). Fakultetsopponent: Armando Bartolazzi, Italien.
Sara Margolin
6 oktober, onkologi, Karolinska institutet, kl 09.00, aulan, plan 6, Södersjukhuset: Family history and breast cancer susceptibility – clinical and molecular studies (Sara Margolin). Fakultetsopponent: Håkan Olsson.
Fredrik Liedberg
6 oktober, urologi, Lunds universitet, kl 09.00, föreläsningssal 1, Universitetssjukhuset i Lund: Invasive bladder cancer – aspects on staging and prognosis (Fredrik Liedberg). Fakultetsopponent: Urs Studer, Schweiz.
Peter Lindvall
13 oktober, neurokirurgi, Umeå universitet, kl 09.00, sal B, 9 tr, Tandläkarhögskolan, Norrlands universitetssjukhus: Hypofractionated conformal stereotactic radiotherapy in the treatment of AVMs and cerebral metastases (Peter Lindvall). Fakultetsopponent: Hans Bolander.
Ali Sheikholvaezin
13 oktober, immunologi, Umeå universitet, kl 09.00, föreläsningssal A 103, byggnad 6, Norrlands universitetssjukhus: Recombinant antibodies and tumour targeting (Ali Sheikholvaezin). Fakultetsopponent: Gregory P Adams, USA.
Håkan Norell
13 oktober, immunbiologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Immunological recognition and tumor escape mechanisms of ovarian carcinoma (Håkan Norell). Fakultetsopponent: Soldano Ferrone, USA.
Maria Hägg Olofsson
20 oktober, onkologi/experimentell onkologi, Karolinska institutet, kl 09.00, föreläsningssalen, CCK, Karolinska Universitetssjukhuset Solna: Translational studies of drug-induced tumor cell death (Maria Hägg Olofsson). Fakultetsopponent: Trond Stokke, Norge.
Johan Pollack
20 oktober, allmän kirurgi, Karolinska institutet, kl 09.00, aulan, Danderyds sjukhus: Preoperative staging and
radiotherapy in rectal cancer surgery (Johan Pollack). Fakultetsopponent: Ann C Lowry, USA.
Charlotta Ryk
20 oktober, miljömedicin, Karolinska institutet, kl 10.00, föreläsningssal 9Q Månen, plan 9, Alfred Nobels Allé 8, Huddinge: Influence of genetic polymorphisms on DNA repair, p53 mutations and cancer risk (Charlotta Ryk). Fakultetsopponent: Håkan Wallin, Danmark.
J Peter Svensson
21 oktober, onkologi, Uppsala universitet, kl 09.15, Auditorium Minus, Gustavianum, Akademigatan 3: Systematic modular approaches to reveal DNA damage responses in mammalian cell (J Peter Svensson). Fakultetsopponent: Jean Bourhis, Frankrike.
Joakim Folkesson
27 oktober, kirurgi, Uppsala universitet, kl 09.15, Grönwallsalen, Akademiska sjukhuset: Rectal cancer: Can the results be further improved? (Joakim Folkesson). Fakultetsopponent: Robert J C Steele, Skottland.
Sissel Andreassen
27 oktober, omvårdnad, Karolinska institutet, kl 09.00, föreläsningssal 03, Sophiahemmets högskola, Lindstedtsvägen 8: Life situation, information needs, and information seeking in patients with oesophageal cancer and their family members (Sissel Andreassen). Fakultetsopponent: Karin Axelsson.
Fuat Celebioglu
27 oktober, kirurgi, Karolinska institutet, kl 09.00, Rolf Luft auditorium, L1:00, Karolinska Universitetssjukhuset Solna: Sentinel node biopsy in breast cancer. Aspects on validation, diagnostics and lymphatic drainage pattern (Fuat Celebioglu). Fakultetsopponent: Per-Ebbe Jönsson.
Anna-Karin Roos
27 oktober, tumörimmunologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Delivery of DNA vaccines against cancer (Anna-Karin Roos). Fakultetsopponent: Federica Cavallo, Italien.
Sofie Svensson Månsson
27 oktober, patologi, Lunds universitet, kl 09.00, föreläsningssalen, Patologihuset, ingång 78, Universitetssjukhuset MAS, Malmö: Invasion and proliferation in malignant cells (Sofie Svensson Månsson). Fakultetsopponent: Geert Berx, Belgien.
SEPTEMBER 2006
Lena Rosenberg
8 september, epidemiologi, Karolinska institutet, kl 9.15, Samuelssonsalen, Tomtebodavägen 6: Hormone related factors and breast cancer – studies of risk and prognosis (Lena Rosenberg). Fakultetsopponent: Janet Daling, USA.
David Lindgren
14 september, experimentell klinisk genetik, Lunds universitet, kl 13.00, föreläsningssal F2, Centralblocket, Universitetssjukhuset i Lund: Molecular profiling of urothelial carcinoma (David Lindgren). Fakultetsopponent: Torben Örntoft, Danmark.
Mårten Fryknäs
21 september, medicinsk genetik, Uppsala universitet, kl 13.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammar-skjölds väg 20: Molecular screening for target discovery in cancer (Mårten Fryknäs). Fakultetsopponent: Hugh Salter.
AUGUSTI 2006
Vaia Stavropoulou
31 augusti, tumörbiologi, Karolinska institutet, kl 13.00, föreläsningssalen, MTC, Theorells väg 1: Role of tripeptidyl peptidase II in cell cycle regulation and tumor progression (Vaia Stavropoulou). Fakultetsopponent: Michael Brandeis, Israel.
JUNI 2006
Ami Albihn
2 juni, cell- och tumörbiologi, Karolinska institutet, kl 13.00, föreläsningssalen, MTC, Theorells väg 1: Roles of Myc and Mad in cell cycle and apoptosis (Ami Albihn). Fakultetsopponent: Sven Påhlman.
Anna Bessö
9 juni, epidemiologi, Karolinska institutet, kl 09.00, Hillarpsalen, Retzius väg 8: Environmental factors and p53 mutation spectrum in lung cancer (Anna Bessö). Fakultetsopponent: Lars Gerhardsson.
Maria Hedelin
9 juni, epidemiologi, Karolinska institutet, kl 09.30, Petrénsalen, Nobels väg 12B: Dietary and genetic factors in the etiology of prostate cancer (Maria Hedelin). Fakultetsopponent: Dag Thelle.
Biying Zheng
9 juni, klinisk genetik, Karolinska institutet, kl 09.15, föreläsningssalen Loben, plan 6, Thoraxhuset N2, Karolinska Universitetssjukhuset Solna: Improved human papillomavirus DNA typing methods and biology of cervical cancer (Biying Zheng). Fakultetsopponent: Ulf Gyllensten.
Annika Bergman
16 juni, klinisk genetik, Göteborgs universitet, kl 13.00, kvinnoklinikens aula, Sahlgrenska Universitetssjukhuset/
Östra: On the genetics of hereditary breast/ovarian cancer; BRCA1, BRCA2 and beyond (Annika Bergman). Fakultetsopponent: Åke Borg.
MAJ 2006
Jonas Nilsson
24 maj, onkologi, Umeå universitet, kl 09.00, sal 244, byggnad 7, Norrlands Universitetssjukhus: The LRIG family: Identification of novel regulators of ErbB signaling with clinical implications in astrocytoma (Jonas Nilsson). Fakultetsopponent: Maria Sibila, Österrike.
Martin Dreilich
20 maj, onkologi, Uppsala universitet, kl 09.15, Skoogsalen, ingång 78, Akademiska sjukhuset: Predictive factors in eso-phageal carcinoma (Martin Dreilich). Fakultetsopponent: Claes Mercke.
Pernilla Roswall
20 maj, patologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Taking pressure of anaplastic thyroid carcinoma: Molecular studies of apoptosis and interstitial hypertension (Pernilla Roswall). Fakultetsopponent: Sven Påhlman.
Helgi Birgisson
19 maj, kirurgi, Uppsala universitet, kl 09.15, Auditorium minor, Museum Gustavianum: Cancer of the colon and rectum: Population based survival analysis and study on adverse effects of radiation therapy for rectal cancer (Helgi Birgisson). Fakultetsopponent: Ragnar Hultborn.
Malin Engelmark
19 maj, medicinsk genetik, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Identifying risk genes for cervical cancer: Using affected sib-pairs and case-control materials from Sweden (Malin Engelmark). Fakultetsopponent: Dan Holmberg.
Patrik Andius
19 maj, urologi, Göteborgs universitet, kl 13.00, aulan, Sahlgrenska Universitetssjukhuset: Carcinoma of the urinary bladder. Long-term prognosis and results of intravesical bacillus Calmette-Guérin treatment (Patrik Andius). Fakultetsopponent: Per-Uno Malmström.
Mikael Persson
13 maj, biomedicinsk strålningsvetenskap, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Antibody mediated radionuclide targeting of HER-2 for cancer diagnostics and therapy: Preclinical studies (Mikael Persson). Fakultetsopponent: Marion De Jong, Nederländerna.
Maria Hedmer
12 maj, experimentell yrkes- och miljömedicin, Lunds universitet, kl 09.15, föreläsningssal F3, Universitetssjukhuset i Lund: Monitoring of occupational exposure to antineoplastic drugs (Maria Hedmer). Fakultetsopponent: Kåre Eriksson.
Christina Ninalga
5 maj, molekylär cellbiologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Cancer immunotherapy: A preclinical study of urinary bladder cancer (Christina Ninalga). Fakultetsopponent: Timothy Ratliff, USA.
Pernilla Viklund
5 maj, kirurgi, Karolinska institutet, kl 10.00, Nanna Svartz auditorium, Karolinska Universitetssjukhuset Solna: Quality of life after esophageal cancer surgery (Pernilla Viklund). Fakultetsopponent: Bruno Walther.
Per Bümming
5 maj, kirurgi, Göteborgs universitet, kl 13.00, hörsal Arvid Carlsson, Academi-cum, Medicinaregatan 3: Gastrointestinal stromal tumours – on diagnosis and treatment (Per Bümming). Fakultetsopponent: Peter J Roberts, Finland.
Åsa Kronblad
5 maj, patologi, Lunds universitet, kl 09.00, föreläsningssalen, Patologihuset, ingång 78, Universitetssjukhuset MAS, Malmö: Role of cyclin D1 as an estrogen receptor cofactor and the influence of hypoxia on estrogen receptor regulation, with focus on prognostic and treatment predictive features in breast cancer (Åsa Kronblad). Fakultetsopponent: Paul van Diest, Nederländerna.
APRIL 2006
Radovan Pilka
28 april, obstetrik och gynekologi, Lunds universitet, kl 13.00, föreläsningssalen, kvinnokliniken, Universitetssjukhuset i Lund: Matrix metalloproteinase-26 (MMP-26) and tissue inhibitor of metalloproteinase-4 (TIMP-4) in normal, hyperplastic, and malignant endometrium (Radovan Pilka). Fakultetsopponent: Etienne Marbaix, Belgien.
Sophia Zackrisson
28 april, epidemiologi, Lunds universitet, kl 09.00, Jubileumsaulan, Medicinskt Forskningscentrum, Universitetssjukhuset MAS, Malmö: Breast cancer screening in an urban Swedish pop-ulation (Sophia Zackrisson). Fakultetsopponent: Steinar Thoresen, Norge.
24 april, onkologi, Göteborgs universitet, kl 13.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Prognostic and predictive factors in laryngeal cancer treated with radiotherapy (Hedda Haugen). Fakultetsopponent: Jens Overgaard, Danmark.
Ann-Charlott Steffen
22 april, biomedicinsk strålningsvetenskap, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Radiolabeled HER-2 binding affibody molecules for tumor targeting: Preclinical studies (Ann-Charlott Steffen). Fakultetsopponent: Ragnar Hultborn.
Truls Gårdmark
21 april, urologi, Uppsala universitet, kl 13.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Urinary bladder carcinoma – studies of outcome of current management and experimental therapy (Truls Gårdmark). Fakultetsopponent: Willem Oosterlinck, Belgien.
Henrik Simán
20 april, medicin, Lunds universitet, kl 09.15, medicinska klinikens aula, ingång 35, Universitetssjukhuset MAS, Malmö: Helicobacter pylori and its association with gastric and oesophageal carcinomas (Henrik Simán). Fakultetsopponent: Olof Nyrén.
Cecilia De Bustos
13 april, experimentell patologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammar-skjölds väg 20: Genetic and epigenetic variation in the human genome: Analysis of phenotypically normal individuals and patients affected with brain tumors (Cecilia De Bustos). Fakultetsopponent: Joseph F Costello, USA.
Anna Lindkvist
7 april, patologi, Uppsala universitet, kl 13.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Activity and regulation of telomerase in malignant cells (Anna Lindkvist). Fakultetsopponent: Göran Roos.
Jenny Bergqvist
7 april, onkologi/experimentell onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: HER2 and TP53 in human breast cancer: Studies of methods and prognostic value (Jenny Bergqvist). Fakultetsopponent: Olle Stål.
Bente Appel Esbensen
7 april, vårdvetenskap, ssk inriktning områdnad, Lunds universitet, kl 13.00, hörsal 1, institutonen för hälsa, vård och samhälle: Elderly persons living with cancer. Quality of life and lived exper-ience (Bente Appel Esbensen). Fakultetsopponent: Carol Tishelman.
Jonas Johansson
6 april, onkologi, Uppsala universitet, kl 13.15, Skoogsalen, ingång 78, Akademiska sjukhuset: Comparative treatment planning in radiotherapy and clinical impact of proton relative biological effectiveness (Jonas Johansson). Fakultetsopponent: Tony Lomax, Schweiz.
MARS 2006
Jan Jacobsen
24 mars, urologi, Umeå universitet, kl 13.00, sal 1, byggnad 10:4, Norrlands Universitetssjukhus: Vascular endothelial growth factor in renal cell carcinoma (Jan Jacobsen). Fakultetsopponent: Peter Ekman.
Karin Tegerstedt
31 mars, experimentell onkologi/onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Studies on polyomavirus virus-like particles as vaccines and vectors for im-mune and gene therapy (Karin Tegerstedt). Fakultetsopponent: Margaret Liu.
Karin Kårehed
10 mars, experimentell patologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammar-skjölds väg 20: Signal transduction in malignant cells – transformation, activation and differentiation (Karin Kårehed). Fakultetsopponent: Jan-Ingvar Jönsson.
Lars Löfgren
10 mars, onkologi/experimentell onkologi, Karolinska institutet, kl 09.00, föreläsningssalen, S:t Görans sjukhus: Hormones and breast cancer – aspects on receptor expression and metabolism (Lars Löfgren). Fakultetsopponent: Stig B Holmberg.
FEBRUARI 2006
Gunnel Sundström
3 februari medicin, Umeå universitet, kl 13.00, sal D, 9 tr, Tandläkarhögskolan, Norrlands Universitetssjukhus: Hyaluronan in normal and malignant bone marrow. A clinical and morphological study with emphasis on development of myelofibrosis (Gunnel Sundström). Fakultetsopponent: Hans Wadenvik.
Cecilia Krona
3 februari, klinisk genetik, Göteborgs universitet, kl 09.00, kvinnoklinikens aula, Sahlgrenska Universitetssjukhuset/Östra: Identification and characterization of candidate genes for neuroblastoma development (Cecilia Krona). Fakultetsopponent: Jan Dumanski.
Parviz Kokhaei
10 februari, onkologi, Karolinska institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Preclinical therapeutic vaccination strategies in malignancies with focus on B-cell chronic lymphocytic leukemia (Parviz Kokhaei). Fakultetsopponent: Magnus Essand.
Michaela Prochazka
24 februari, medicinsk epidemiologi, Karolinska institutet, kl 09.00, Petrénsalen, Nobels väg 12 B: The risk of second primary lung carcinoma in breast cancer patients (Michaela Prochazka). Fakultetsopponent: Dick Killander.
Annika Krona
24 februari, patologi, Göteborgs universitet, kl 13.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: Gene expression studies in human astrocytoma, with emphasis on oncostatin M induced effects (Annika Krona). Fakultetsopponent: Marie Arsenian-Henriksson.
JANUARI 2006
Fredrik Lindmark
20 januari, onkologi, Umeå universitet, kl 13.00, Lionsalen, byggnad 7, Norrlands Universitetssjukhus: Prostate cancer and inflammatory genes (Fredrik Lindmark). Fakultetsopponent: William B Nelson, USA.
Paula Maguire
20 januari, klinisk genetik, Karolinska institutet, kl 09.30, Rolf Lufts auditorium, L1:00, Karolinska Universitetssjukhuset Solna: Investigation of the genetic basis of familial non-BRCA1/2 breast cancer (Paula Maguire). Fakultetsopponent: Peter Devilee, Nederländerna.
Lena Sharp
20 januari, onkologi, Karolinska institutet, kl 09.00, Ihresalen, Södersjukhuset: Aspects of nursing care for patients with head and neck cancer receiving radiation therapy (Lena Sharp). Fakultetsopponent: Linda Sarna, USA.
Catharina Ihre Lundgren
27 januari, epidemiologi, Karolinska institutet, kl 09.00, Petrénsalen, Nobels väg 12 B: Incidence and prognosis of differentiated thyroid cancer in Sweden (Catharina Ihre Lundgren). Fakultetsopponent: Ian Hay, USA.
Helena Lexander
27 januari, patologi, cytologi, experimentell patologi, Karolinska institutet, kl 09.00, föreläsningssalen, Cancer Centrum Karolinska, Karolinska Universitetssjukhuset Solna: Protein expression in prostate cancer (Helena Lexander). Fakultetsopponent: Michael J Dunn, Irland.
DECEMBER 2005
Nina Ohlson
16 december, patologi, Umeå universitet, kl 13.00, sal E04, byggnad 6 E, Norrlands Universitetssjukhus: Early effects of castration therapy in non-malignant and malignant prostate tissue (Nina Ohlson). Fakultetsopponent: Marja T Nevalainen, USA.
Peter Hovstadius
16 december, klinisk farmakologi, Uppsala universitet, kl 09.15, Rudbecksalen, Rudbecklaboratoriet: Preclinical and clinical development of the novel cyanoguanidine CHS 828 for cancer treatment (Peter Hovstadius). Fakultetsopponent: Sigurd Vitols.
Eva Lundström
16 december, obstetrik och gynekologi, Karolinska institutet, kl 09.00, Skandiasa-len, Astrid Lindgrens barnsjukhus, Karolinska Universitetssjukhuset Solna: Mammographic breast density and postmenopausal hormone therapy (Eva Lundström). Fakultetsopponent: Mats Hammar.
Henryk A Domanski
16 december, patologi, Lunds universitet, kl 13,00, föreläsningssalen, patologiska/cytologiska kliniken, Universitetssjukhuset: Fine needle aspiration diagnosis of spindle cell tumors of soft tissue, including the use of ancillary methods, and correlation with clinical data (Henryk A Domanski). Fakultetsopponent: Björn Hagmar, Norge.
Yaping Zhang
characterized in an in-vitro model of asthma (Yaping Zhang). Fakultetsopponent: Ulf Simonsen, Danmark.
Göran Jönsson
13 december, experimentell onkologi, Lunds universitet, kl 09.00, föreläsningssalen, plan 1, Universitetssjukhuset i Lund: Genetic characterization of malignant melanoma and breast cancer (Göran Jönsson). Fakultetsopponent: Graham J Mann, Austra-lien.
Catrina Sergiu-Bogdan
12 december, endokrinologi, Karolinska institutet, kl 09.00, föreläsningssalen, CMM, L8:08, Karolinska Universitetssjukhuset Solna: Regulators of angiogenesis in diabetes and tumors (Catrina Sergiu-Bogdan). Fakultetsopponent: Andrew Boulton, England.
Padideh Davoodpour
9 december, medicinsk cellbiologi, Uppsala universitet, kl 09.15, sal B22, BMC, Husargatan 3: 2-ME-induced apoptotic signaling in prostate cancer PC3 cells (Padideh Davoodpour). Fakultetsopponent: Sten Nilsson.
Meit A Björndahl
9 december, tumörbiologi, Karolinska institutet, kl 09.00, föreläsningssalen, MTC, Theorells väg 1: Lymphangiogenesis and lymphatic metastasis (Meit A Björndahl). Fakultetsopponent: Bruce Zetter, USA.
Maria Gustafsson Liljefors
9 december, onkologi/experimentell onkologi, Karolinska institutet, kl 10.00, Ra-diumhemmets föreläsningssal, Karolinska Universitetssjukhuset Solna: Immunother-apy with the anti-EpCAM monoclonal antibody and cytokines in patients with colorectal cancer. A clinical and experimental study (Maria Gustafsson Liljefors). Fakultetsopponent: Torgny Stigbrand.
Hayrettin Guven
9 december, experimentell medicin, Karolinska institutet, kl 09.00, föreläsningssalen 4U Solen, Alfred Nobels Allé 8: The therapeutic potential of ex vivo expanded natural killer (NK) cells for immunotherapy of cancer (Hayrettin Guven). Fakultetsopponent: Mikael Jondal.
Karin Petruson
8 december, öron-, näs- och halssjukdomar, Göteborgs universitet, kl 09.00, hörsal Arvid Carlsson, Academicum, Medicinaregatan 3: The impact of treatment on health related quality of life in head and neck cancer (Karin Petruson). Fakultetsopponent: Göran Laurell.
Mats Nordgren
3 december, öron-, näs- och halssjukdomar, Lunds universitet, kl 09.15, Jubileumsaulan, Universitetssjukhuset MAS, Malmö: Health-related quality of life in head and neck cancer. A five-year prospective multicenter study (Mats Nordgren). Fakultetsopponent: Ulf Zätterström.
Gunnar Söderdahl
2 december, transplantationskirurgi, Karolinska institutet, kl 09.00, föreläsningssal R64, Karolinska Universitetssjukhuset Huddinge: Liver transplantation and the role of adjuvant therapy for advanced primary liver tumours (Gunnar Söderdahl). Fakultetsopponent: Hans J Schlitt, Tyskland.
NOVEMBER 2005
Johan Skog
25 november, virologi, Umeå universitet, kl 09.00, Lionsalen, byggnad 7, Norrlands Universitetssjukhus: The quest for new adenovirus gene therapy vectors for treatment of glioma tumors (Johan Skog). Fakultetsopponent: Stephan Kochanek, Tyskland.
Pia Jestin
25 november, kirurgi, Uppsala universitet, kl 09.15, Auditorium Minor, Museum Gustavianum, Akademigatan 3: Colorectal cancer: Audit and health economy in colorectal cancer surgery in a defined Swedish population (Pia Jestin). Fakultetsopponent: Jörgen Rutegård.
Kristina Hellman
25 november, onkologi/experimentell onkologi, Karolinska institutet, kl 10.00, föreläsningssalen, Radiumhemmet, Karolinska Universitetssjukhuset Solna: Vaginal carcinoma: Studies on etiology and prognostic factors (Kristina Hellman). Fakultetsopponent: Bengt Sorbe.
Per J Nilsson
25 november, kirurgi, Karolinska institutet, kl 09.00, Bringsalen, 1 tr, Ersta Hotell & Konferens, Erstagatan 1 K: On treatment and prognosis in epidermoid anal cancer (Per J Nilsson). Fakultetsopponent: J M A Northover, England.
Kristina Cederquist
18 november, medicinsk genetik, Umeå universitet, kl 09.00,
sal Betula, hus 6M, Norrlands Universitetssjukhus: Genetic and epidemiological studies of hereditary colorectal cancer (Kristina Cederquist). Fakultetsopponent: Mef Nilbert.
Pernilla C Karlsson
11 november, molekylär toxikologi, Karolinska institutet, kl 09.00,
sal Solen, plan 8, Alfred Nobels Allé, Huddinge: Biomarkers for
colon cancer: ×Applications in human and rat studies (Pernilla C Karlsson).
Fakultetsopponent: Dennis Corpet, Frankrike.
Lars Bryngelson Ohlsson
11 november, tumörimmunologi, Lunds universitet, kl 13.00, GK-salen, BMC,
Sölvegatan 19: Studies of mesenchymal progenitor cells and tumour growth,
integrins and matrix metalloproteinases (Lars Bryngelson Ohlsson). Fakultetsopponent: Staffan Johansson.
Ulrika
Segersten
8 november, kirurgi, Uppsala universitet, kl 09.15, Rosénsalen,
ingång 95, Akademiska sjukhuset: Vitamin D hydroxylating enzymes and
analogues in parathyroid tumors and breast cancer (Ulrika
Segersten). Fakultetsopponent: Martin Bäckdahl.
Margaretha Eriksson
3 november, allmänmedicin, Uppsala universitet, kl 13.15,
Rudbecksalen, Rudbeck-laboratoriet: The impact of birth weight on
cardiovascular risk factors, coronary heart disease and prostate
cancer: Population-based studies of men born in 1913 and followed up
until old age (Margaretha Eriksson). Fakultetsopponent: Lena
Hulthén.
OKTOBER 2005
Louise Bergman
14 oktober, oftalmiatrik, Karolinska institutet, kl 09.00, aulan,
S:t Eriks ögonsjukhus, Polhemsgatan 50: Uveal melanoma:
Epidemiological and clinical aspects (Louise Bergman).
Fakultetsopponent: Marie Diener-West, USA.
Xiaolei Zhou
14 oktober, klinisk genetik, Karolinska institutet, kl 09.30,
thoraxklinikernas aula, Karolinska Universitetssjukhuset Solna:
Molecular genetic studies of colorectal cancer (Xiaolei Zhou).
Fakultetsopponent: Claes Wadelius.
Xiaojuan Sun
21 oktober, patologi, Karolinska institutet, kl 09.15, Birkeaulan 2,
F53, Karolinska Universitetssjukhuset Huddinge: Studies on
mesothelial differentiation: Prognostic and therapeutic approaches
to malignant mesothelioma (Xiaojuan Sun). Fakultetsopponent: Erik
Larsson.
Eva Baecklund
7 oktober, medicin, Uppsala universitet, kl 09.15, Fåhraeussalen,
patologen, ingång C5, Akademiska sjukhuset: Associations between
rheumatoid arthritis and malignant lymphomas (Eva Baecklund).
Fakultetsopponent: Tore Kvien, Norge.
Eva Brandén
7 oktober, lungmedicin, Karolinska institutet, kl 09.00,
thoraxklinikernas föreläsningssal, N2:U1, Karolinska
Universitetssjukhuset Solna: Chronic infection with Chlamydia
pneumoniae in COPD and lung cancer (Eva Brandén). Fakultetsopponent:
Christer Janson.
Catarina Jansson
7 oktober, epidemiologi, Karolinska institutet, kl 09.00,
Samuelssonsalen, Tomtebodavägen 6: Occupational and socio-economic
factors in the etiology of cancer of the esophagus and gastric
cardia (Catarina Jansson). Fakultetsopponent: Elsebeth Lynge,
Danmark.
Alexander Valdman
7 oktober, onkologi/patologi, Karolinska institutet, kl 09.00,
föreläsningsalen, Cancer Centrum Karolinska, Karolinska
Universitetssjukhuset Solna: A study of the transition from
premalignancy to clinical prostate cancer (Alexander Valdman).
Fakultetsopponent: Ola Bratt.
Anna Danielsson
7 oktober, onkologi, Göteborgs universitet, kl 13.00, hörsal Arvid
Carlsson, Academicum, Medicinaregatan 3: Intrinsic radiosensitivity
and molecular targets for tumour radiosensitization of head and neck
cancer with special reference to chromosomal instability and
pentoxifylline (Anna Danielsson). Fakultetsopponent: Ingela
Turesson.
Kajsa Paulsson
7 oktober, experimentell klinisk genetik, Lunds universitet, kl
10.00, föreläsningssal F3, Centralblocket, Universitetssjukhuset i
Lund: Trisomies in hematologic malignancies (Kajsa Paulsson).
Fakultetsopponent: Christine Harrison, England.
SEPTEMBER 2005
Cecilia Gunnarsson
22 september, onkologi, Linköpings universitet, kl 09.00, ingång 65,
Universitetssjukhuset i Linköping: Steroid converting enzymes in
breast cancer (Cecilia Gunnarsson). Fakultetsopponent: Tommy
Fornander.
Anders Bratt
16 september, onkologi/experimentell onkologi, Karolinska
institutet, kl 10.00, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: The role of angiomotin in endothelial
cell motility and cell-cell junction formation (Anders Bratt).
Fakultetsopponent: Carl-Henrik Heldin.
Marie-Thérése Stockhausen
16 september, molekylär medicin, Lunds universitet, kl 09.15,
patologens föreläsningssal, Universitetssjukhuset MAS, Malmö: Notch
signaling in human neuroblastoma cells (Marie-Thérése Stockhausen).
Fakultetsopponent: R Versteeg, Nederländerna.
JUNI 2005
Karin Ekström Smedby
3 juni, medicinsk epidemiologi, Karolinska institutet, kl 09.00, sal
Rockefeller, Nobels väg 11: Ultraviolet light, autoimmune disorders
and the etiology of malignant lymphomas (Karin Ekström Smedby).
Fakultets-opponent: Robert N Hoover, USA.
Katarina Omholt
3 juni, onkologi/experimentell onkologi, Karolinska institutet, kl
10.00, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: Activating proto-oncogene mutations in
human cutaneous melanoma (Katarina Omholt). Fakultetsopponent: Per
Guldberg, Danmark.
Östen Helgesson
3 juni, allmänmedicin, Göteborgs universitet, kl 09.00, sal 2119,
avd för allmänmedicin, hus 2, Arvid Wallgrens Backe: Psychosocial
aspects of cancer in women: The prospective population study of
women in Göteborg (Östen Helgesson). Fakultetsopponent: Sigvard
Mölstad.
Nishtman Dizeyi
3 juni, urologi, Lunds universitet, kl 13.00, Lilla aulan,
Medicinskt forskningscentrum, ingång 59, Universitetssjukhuset MAS,
Malmö: Neuroendocrine receptors in prostate cancer progression with
reference to serotonin receptors (Nishtman Dizeyi).
Fakultets-opponent: F C Hamdy, England.
Jenny Karlsson
3 juni, molekylär medicin, Lunds universitet, kl 09.15,
föreläsningssalen, patologihuset, Universitetssjukhuset MAS, Malmö:
Effects of arsenic trioxide and hypoxia in multidrug-resistant
neuroblastoma (Jenny Karlsson). Fakultetsopponent: Maria Shoshan.
Maxim Pavlenko
10 juni, immunbiologi/tumörimmunologi, Karolinska institutet, kl
09.00, föreläsningssalen, Cancer Centrum Karolinska, Karolinska
Universitetssjukhuset Solna: Induction of T-cell responses against
PSA by plasmid DNA immunization (Maxim Pavlenko). Fakultetsopponent:
Christian Ottensmeier, England.
Helén Nilsson
10 juni, molekylär medicin, Lunds universitet, kl 09.15,
föreläsningssalen, Patologihuset, Universitetssjukhuset MAS, Malmö:
Hypoxia and differentiation in human neuroblastoma cells (Helén
Nilsson). Fakultetsopponent: Joachim Fandrey, Tyskland.
MAJ 2005
Wing-Shing Cheng
4 maj, klinisk immunologi, Uppsala universitet, kl 13.15,
Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20: TARP
promoter-based prostate cancer gene therapy: From development to
application (Wing-Shing Cheng). Fakultetsopponent: Cecilia Lundberg.
Erik Björk
13 maj, medicinsk genetik, Karolinska institutet, kl 09.00,
Skandiasalen, Astrid Lindgrens barnsjukhus, Karolinska
Universitetssjukhuset Solna: Genetic studies of follicular and
mantle cell lymphoma (Erik Björk). Fakultetsopponent: Thoas
Fioretos.
Karin Jirström
13 maj, patologi, Lunds universitet, kl 09.00, patologiska
institutionens föreläsningssal, Universitetssjukhuset MAS, Malmö:
Tissue microarray perspectives on cyclin D1 in breast cancer
progression, prognosis and prediction (Karin Jirström).
Fakultetsopponent: Carl Blomqvist.
Joacim Stalfors
18 maj, öron-, näs- och halssjukdomar, Göteborgs universitet, kl
09.00, aulan, Sahlgrenska Universitetssjukhuset: Quality studies of
a multidisciplinary tumour conference for head and neck oncology
(Joacim Stalfors). Fakultetsopponent: Sten Hellström.
Ulrika Andersson
20 maj, onkologi, Umeå universitet, kl 12.00, sal 244, 2 tr, byggnad
7, Norrlands Universitetssjukhus: Experimental studies in brain
tumours with special regard to multi-drug resistance and the ErbB
receptor family (Ulrika Andersson). Fakultetsopponent: Erik
Blomqvist.
Brigitte Wilczek
20 maj, diagnostisk radiologi, Karolinska institutet, kl 13.00,
föreläsningssal C1-87, Karolinska Universitetssjukhuset Huddinge:
Application of nuclear medicine methods in patients with breast
cancer (Brigitte Wilczek). Fakultetsopponent: Jan-Erik Westlin.
Adil Babiker
23 maj, klinisk immunologi, Uppsala universitet, kl 13.15,
Rudbecksalen, Rudbeck-laboratoriet, Dag Hammarskjölds väg 20:
Prostasome modulation of blood cascade system and phosphoprotein
reactions with focus on prostate cancer (Adil Babiker).
Fakultetsopponent: Michael Wilson, USA.
Gustav Grafström
23 maj, medicinsk radiofysik, Lunds universitet, kl 09.00,
onkologiska klinikens föreläsningssal, Universitetssjukhuset i Lund:
Radiobiological studies with low energy ionizing radiation –
dosimetric aspects (Gustav Grafström). Fakultetsopponent: Hans
Lund-qvist.
Jeffrey R Yachnin
27 maj, experimentell onkologi/onkologi, Karolinska institutet, kl
09.45, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: Chemical, pharmaco-kinetic and
biological aspects of platinum-based drugs (Jeffrey R Yachnin).
Fakultets-opponent: Curt Peterson.
Maria Stighall
28 maj, patologi, Lunds universitet: Cyclin E overexpression and
associated events in human breast cancer (Maria Stighall).
Fakultetsopponent: Dan Grandér.
APRIL 2005
Zhongmin Wang
6 april, onkologi, Lunds universitet, kl 09.15, onkologiska
klinnikens föreläsningssal, Universitetssjukhuset i Lund:
Radioimmunotherapy and extracorporeal adsorption: Preclinical
studies of the pharmacokinetics and biotinylation of
radioimmunoconjugates in immunocompetent rats (Zhongmin Wang).
Fakultetsopponent: Torgny Stigbrand.
Liselotte Dahlgren
8 april, onkologi/experimentell onkologi, Karolinska institutet, kl
09.00, föreläsningssalen, Cancer Centrum Karolinska, Karolinska
Universitetssjukhuset Solna: Studies on the presence and influence
of human pap-illomavirus (HPV) in head and neck tumors (Liselotte
Dahlgren). Fakultetsopponent: Bodil Norrild, Danmark.
Xiaolei
Fang
8 april, urologi, Karolinska institutet, kl 09.45, föreläsningssal
P8:01, Radiumhemmet, Karolinska Universitetssjukhuset Solna: Early
oncogenic events and defective apoptosis in prostate cancer (Xiaolei
Fang). Fakultetsopponent: Anders Bjartell.
Wen-Hui Weng
12 april, medicinsk genetik, Karolinska institutet: Molecular
cytogenetic studies of soft tissue sarcoma: with focus on prognosis
and acquired events (Wen-Hui Weng). Fakultetsopponent: Göran
Stenman.
Lennart Olofsson
15 april, radiofysik, Umeå universitet, kl 13.00, sal 244, byggnad
7, Norrlands Universitetssjukhus: Energy and intensity modulated
radiation therapy with electrons (Lennart Olofsson).
Fakultetsopponent: Erik Traneus.
Mariann
Hedström
21 april, vårdvetenskap, Uppsala universitet, kl 13.15, aulan,
Döbelnsgatan 2: Distress among adolescents with cancer (Mariann
Hedström). Fakultetsopponent: Ulla Qvarnström.
Anna Sjödin
22 april, onkologi, Umeå universitet, kl 09.00, Lionsalen, plan 2,
byggnad 7, Norrlands Universitetssjukhus: Human secreto-globins in
normal and neoplastic cells and tissues (Anna Sjödin).
Fakultetsopponent: Mårten Fernö.
Lachmi Jenndahl
22 april, medicinsk och fysiologisk kemi, Göteborgs universitet, kl
09.00, hörsal Ar-vid Carlsson, Medicinaregatan 3: Effects of c-erbB2
signaling on morphogenesis and cell adhesion in mammary epithelial
cells (Lachmi Jenndahl). Fakultetsopponent: Donald Gullberg, Norge.
Theodoros Foukakis
29 april, medicinsk genetik, Karolinska institutet, kl 09.15,
föreläsningssalen, CMM, L8:00, Karolinska Universitetssjukhuset
Solna: Basic and translational studies of follicular thyroid
neoplasia (Theodoros Foukakis). Fakultetsopponent: Massimo Santoro,
Italien.
Karin Sennfält
29 april, medicinsk teknologiutvärdering, Linköpings universitet, kl
09.00, Berzeliussalen, ingång 65, Universitetssjukhuset i Linköping:
Economic studies of health technology changes in prostate cancer
care (Karin Sennfält). Fakultetsopponent: Ivar Kristiansen, Norge.
Johanna Andersson
29 april, patologi, Göteborgs universitet, kl 13.00, hörsal Arvid
Carlsson, Academicum, Medicinaregatan 3: Gastrointestinal stromal
tumors - pathogenetic mechanisms, phenotypic characterization and
prognosis (Johanna Andersson). Fakultetsopponent: Olle Larsson.
MARS 2005
Johan Vallon-Christersson
30 mars, experimentell onkologi, Lunds universitet, kl 13.00,
Segerfalksalen, Wallenberg Neurocentrum: Functional and molecular
characterization of BRCA1 and BRCA2 associated breast cancer (Johan
Vallon-Christersson). Fakultetsopponent: John Quackenbush, USA.
Ulrike Kronenwett
11 mars, patologi, cytologi, experimentell patologi, Karolinska
institutet, kl 09.00, föreläsningssalen, Cancer Centrum Karolinska:
Genome instability, gene expression and prognosis in breast cancer
(Ulrike Kronenwett). Fakultetsopponent: Jahn M Nesland, Norge.
Christina Löfgren
11 mars, hematologi, Karolinska institutet, kl 09.00,
föreläsningssal R64, Karolinska Universitetssjukhuset Huddinge:
Pharmacological and clinical studies of new ways to improve
cytostatic treatment of acute myelocytic leukemia – in vitro and in
vivo studies (Christina Löfgren). Fakultetsopponent: Anders Wahlin.
Patrick Buckley
17 mars, experimentell patologi, Uppsala universitet, kl 09.15,
Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20:
Development and application of microarray-based comparative genomic
hybridization: Analysis of neurofibromatosis type-2, Schwannomatosis
and related tumors (Patrick Buckley). Fakultetsopponent: Olivier
Delattre, Frankrike.
Hamdiye Erdal
18 mars, onkologi/experimentell onko-logi, Karolinska institutet, kl
13.30, föreläsningssalen, CCK, Karolinska Universitetssjukhuset
Solna: Characterization of the mechanisms of action of anticancer
agents in vitro and monitoring their effects in vivo (Hamdiye
Erdal). Fakultetsopponent: Karin Öllinger.
FEBRUARI 2005
Bahram
Rashidkhani
4 februari, epidemiologi, Karolinska institutet, kl 13.00,
Hillarpsalen, Retzius väg 8: Diet and renal cell carcinoma (Bahram
Rashidkhani). Fakultetsopponent: Katherine L Tucker, USA.
Anna Dahlén
4 februari, experimentell klinisk genetik, Lunds universitet, kl
09.30, föreläsningssal F1, Universitetssjukhuset i Lund: Genetic
characterization of bone and soft tissue tumors (Anna Dahlén).
Fakultetsopponent: Sverre Heim, Norge.
Kajsa
Ericson
11 februari, experimentell onkologi, Lunds universitet, kl 09.00,
Segerfalksalen, Wallenberg Neurocentrum: Tumors associated with
HNPCC: Defective mismatch repair and familial risk of cancer (Kajsa
Ericson). Fakultetsopponent: Henrik Grönberg.
Magnus Bäcklund
11 februari, patologi, cytologi, experimentell patologi, Karolinska
institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: The epidemiology, biology and genetics
of human astrocytic tumours (Magnus Bäcklund). Fakultetsopponent:
Göran Landberg.
Natalia Issaeva
11 februari, tumörbiologi, Karolinska institutet, kl 10.00, MTC:
Selective induction of apoptosis in tumors by small molecules
re-activating p53 (Natalia Issaeva). Fakultets-opponent: Andrei
Gudkov, USA.
Lena Thyrell
18 februari, onkologi/experimentell onkologi, Karolinska institutet,
kl 10.00, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: To catch a killer – on the mechanisms
of interferon alpha in-
duced apoptosis (Lena Thyrell). Fakultetsopponent: Lars-Gunnar
Larsson.
Malin Nilsson
18 februari, experimentell klinisk genetik, Lunds universitet, kl
10.00, föreläsningssal 3, Centralblocket, Universitetssjukhuset i
Lund: Molecular cytogenetic characterization of chromosome
aberrations in soft tissue and bone tumors (Malin Nilsson).
Fakultets-opponent: Januaz Limon, Polen.
Xiangkui Mu
25 februari, onkologi, Umeå universitet, kl 10.00, sal 244,
Norrlands Universitetssjukhus: Clinical application of intensity and
energy modulated radiotherapy with photon and electron beams
(Xiangkui Mu). Fakultetsopponent: Erik Blomqvist.
JANUARI 2005
Karin Fransén
21 januari, medicinsk cellbiologi, ssk medicinsk genetik, Linköpings
universitet, kl 09.00, Berzeliussalen, ingång 65,
Universitetssjukhuset i Linköping: Molecular genetic aspects of
colorectal cancer development (Karin Fransén). Fakultetsopponent:
Annika Lindblom.
DECEMBER 2004
Fredrik Hellborg
17 december, onkologi/experimentell onkologi, Karolinska institutet,
kl 09.30, föreläsningssalen, CCK, Karolinska Universitetssjukhuset
Solna: Identification, cloning and characterization of the p53
induced gene human wig-1 (Fredrik Hellborg). Fakultets-opponent:
Matthias Dobbelstein, Tyskland.
Stefan Lönn
17 december, epidemiologi, Karolinska institutet, kl 09.00,
föreläsningssal Cesar, Berzeliuslaboratoriet, Berzelius väg 3:
Mobile phone use and risk of intracranial tumors (Stefan Lönn).
Fakultetsopponent: Valerie Beral, England.
Qianren Jin
17 december, molekylär epidemiologi, Karolinska institutet, kl
09.30, CNTs seminarierum, Novum, Huddinge: Search for
sus-ceptibility loci and candidate genes for breast cancer (Qianren
Jin). Fakultetsopponent: Ann-Christine Syvänen.
Dongsheng Guo
11 december, onkologi, ssk neuroonkologi, Umeå universitet, kl
09.00, sal 244, byggnad 7, Norrlands Universitetssjukhus: The
identification and characterisation of LRIG gene family with
emphasis on malignant glioma (Dongsheng Guo). Fakultetsopponent:
Tomas Ekström.
Mikael Öman
10 december, kirurgi, Umeå universitet, kl 09.00, sal B,
Tandläkarhögskolan: Intraperitoneal 5-fluorouracil treatment of
cancer – clinical and experimental studies (Mikael Öman).
Fakultetsopponent: Johan Permert.
Gunvor Ödling
9 december, omvårdnadsforskning, Umeå universitet, kl 09.00, aulan,
Vårdvetarhuset: Caregivers’ perceptions of needs for support a mong
women with breastcancer, their relatives and themselves in a
surgical ward (Gunvor Ödling). Fakultetsopponent: Margarethe
Lorensen, Norge.
Jacob Engellau
3 december, onkologi, Lunds universitet, kl 13.00, Fernströmsalen,
BMC, Sölvegatan 19: Prognostic factors in soft tissue sarcoma.
Tissue microarray for immunostaining, the importance of whole-tumor
sections and time-dependence (Jacob Engellau). Fakultetsopponent:
Gunnar Sæter, Norge.
Eva Elmberger
3 december, omvårdnad, Karolinska institutet, kl 13.00, hörsal 1,
Alfred Nobels allé 23, Campus Huddinge: Att som förälder få en
cancersjukdom. Erfarenheter av föräldra-ansvar (Eva Elmberger).
Fakultetsopponent: Ulla Forinder.
Kristian Hallermalm
3 december, immunbiologi/tumörimmunologi, Karolinska institutet, kl
09.30, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: Modulation of tumor sensitivity to
effector mechanisms of cytotoxic lymphocytes (Kristian Hallermalm).
Fakultetsopponent: Jan Andersson.
Mats Lindblad
3 december, kirurgi, Karolinska institutet, kl 10.00, Petrénsalen,
Wargentinhuset, Nobels väg 12B: Aspects on the etiology of
esophageal and gastric cancer (Mats Lindblad). Fakultetsopponent:
Bruno Walther.
Ingalill Koinberg
3 december, vårdvetenskap, ssk omvårdnad, Linköpings universitet, kl
13.00, Berzeliussalen, ingång 65, Universitetssjukhuset i Linköping:
Traditional or individualised follow-up in women after breast cancer
surgery (Ingalill Koinberg). Fakultetsopponent: Gun Nordström.
NOVEMBER 2004
Peter Åberg
26 november, medicinsk teknik, Karolinska institutet, kl 10.00,
hörsalen, plan 4, Novum, Huddinge: Skin cancer as seen by electrical
impedance (Peter Åberg). Fakultetsopponent: Rod Smallwood, England.
Zhiwen Liu
19 november, lungmedicin, allergologi, Karolinska institutet, kl
09.00, föreläsningssal C1-87, Karolinska Universitetssjukhuset
Huddinge: Matrix metalloproteases and cell motility in malignant
mesothelioma (Zhiwen Liu). Fakultetsopponent: Håkan Hedman.
Botond K Szabo
19 november, diagnostisk radiologi, Karolinska institutet, kl 09.00,
föreläsningssal M63, Karolinska Universitetssjukhuset Huddinge:
Dynamic magnetic resonance imaging of the breast: Imaging features
for diagnosis and prognosis of breast cancer (Botond K Szabo).
Fakultetsopponent: Per Skaane, Norge.
Lisa Rydén
19 november, kirurgi, Lunds universitet, kl 10.00, patologens stora
föreläsningssal, ingång 78, Universitetssjukhuset MAS, Malmö:
Tamoxifen response in primary breast cancer with special reference
to tumour-specific VEGF-A and VEGFR2 (Lisa Rydén).
Fakultetsopponent: Jonas Bergh.
Erik Holmberg
12 november, onkologi, Göteborgs universitet: Methodological aspects
on excess cancer risk after exposure to ionizing radiation (Erik
Holmberg). Fakultetsopponent: Sören Mattsson.
Xinjun Li
5 november, molekylär epidemiologi, Karolinska institutet, kl 09.30,
CNTs seminarierum, Novum, Huddinge: Familial risks for cancer with
reference to lung cancer (Xinjun Li). Fakultetsopponent: Per
Gustavsson.
OKTOBER 2004
Marie Fischer
29 oktober, onkologi, Uppsala universitet, kl 09.15, Rudbecksalen,
Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Mast cells in Hodgkin
lymphoma: or »What’s a nice cell like you doing in a tumour like
this?« (Marie Fischer). Fakultetsopponent: Tor Olofsson.
Ada Girnita
15 oktober, patologi, cytologi/experimentell patologi, Karolinska
institutet, kl 09.30, föreläsningssalen, Cancer Centrum Karolinska,
Karolinska Universitetssjukhuset Solna: Targeting insulin-like
growth factor-1 receptor in cancer (Ada Girnita). Fakultetsopponent:
Ada Sacchi, Italien.
Caroline Lundgren
15 oktober, onkologi, experimentell onkologi, Karolinska institutet,
kl 10.00, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: Endometrial carcinoma: prognostic
factors and protein expression profiling (Caroline Lundgren).
Fakultetsopponent: Tuula Salmi, Finland.
Hans-Olof Nilsson
15 oktober, medicinsk mikrobiologi, Lunds universitet, kl 13.00,
patologens föreläsningssal, Sölvegatan 23: Enteric Helicobacter and
H pylori in chronic inflammation and cancer of the hepatobiliary
tract and pancreas (Hans-Olof Nilsson). Fakultetsopponent: Robert
Owen, England.
Sara Wedrén
1 oktober, epidemiologi, Karolinska institutet, kl 09.15,
farmakologens föreläsningssal, Nanna Svartz väg 2: Genetic
susceptibililty to breast and endometrial cancer (Sara Wedrén).
Fakultetsopponenet: Christin Ambrosone, USA.
SEPTEMBER 2004
Haixin Lei
24 september, molekylär epidemiologi, Karolinska institutet, kl
10.00, sal 4V, Alfred Nobels Allé 8, Huddinge: Functional analysis
of genetic variants in putative low penetrance breast cancer genes
(Haixin Lei). Fakultetsopponent: Henrik Grönberg.
Li Li
24 september, tumörimmunologi, Lunds universitet, kl 09.00, Rune
Grubbsalen, BMC, Sölvegatan 19: SOCS family and its function in
regulation of intracellular signalling (Li Li). Fakultetsopponent:
Ken Siddle, England.
Fredrik Petersson
24 september, patologi, Linköpings universitet, kl 10.00, aulan,
Länssjukhuset Ryhov, Jönköping: Chronic gastritis in a sample of the
general population – Helicobacter pylori infection, metaplastic
transformation, epithelial proliferation, p53- and p21 expression
and antral mucosal gastrin content with reference to gastric
carcinoma development (Fredrik Petersson). Fakultetsopponent: Roger
Stenling.
Cecilia G Bredin
24 september, lungmedicin och allergologi, Karolinska institutet,
kl 09.00, föreläsningssalen M63, Karolinska Universitetssjukhuset
Huddinge: Studies of cell migration and matrix protease production
in human lung cancer cell lines (Cecilia G Bredin).
Fakultetsopponent: Rolf Lewensohn.
Haixin Lei
24 september, molekylär epidemiologi, Karolinska institutet, kl
10.00, sal 4V, Alfred Nobels Allé 8, Huddinge: Functional analysis
of genetic variants in putative low penetrance breast cancer genes
(Haixin Lei). Fakultetsopponent: Henrik Grönberg.
JUNI 2004
Fredrik Wiklund
4 juni, onkologi, Umeå universitet, kl 13.00, sal 244, byggnad 7,
Norrlands Universitetssjukhus: Genetic epidemiology of prostate
cancer (Fredrik Wiklund). Fakultetsopponent: Douglas Easton,
England.
institutet, kl 09.15,
föreläsningssal R64, Karolinska Universitetssjukhuset Huddinge:
Invasion promoting factors in endometriotic and endometrial tissue
(Christine Bruse). Fakultetsopponent: Bertil Casslén.
Peter
Conner
4 juni, obstetrik och gynekologi, Karolinska institutet, kl 09.00,
lilla föreläsningssalen, Astrid Lindgrens barnsjukhus, Karolinska
Universitetssjukhuset Solna: Hormone therapy and the breast &
aspects on proliferation, apoptosis and mammographic density (Peter
Conner). Fakultetsopponent: Peter Kenemans, Nederländerna.
Katja Fall
4 juni, epidemiologi, Karolinska institutet, kl 09.00,
föreläsningssalen, MTC, Theorells väg 1: Medical interventions and
gastric cancer risk & an observational approach (Katja Fall).
Fakultetsopponent: David Forman, England.
Ethel Ramfelt
10 juni, omvårdnad, Karolinska institutet, kl 09.00, hörsal 1,
Alfred Nobels allé 23, Huddinge: Patients with cancer & their
preferences and experiences of participation in treatment and care
decisions (Ethel Ramfelt). Fakultetsopponent: Ella Danielsson.
Frida Abel
10 juni, klinisk genetik, Göteborgs universitet, kl 09.00,
kvinnoklinikens aula, Sahlgrenska Universitetssjukhuset/…stra:
Genet-ic studies of neuroblastoma with emphasis on the apoptotic
pathway (Frida Abel). Fakultetsopponent: Catharina Larsson.
Lena Ohlson
10 juni, molekylär toxikologi, Karolinska institutet, kl 09.30,
hörsalen, plan 4, Novum, Huddinge: In vivo studies of cell cycle
regulating proteins in rats during liver regeneration and during
promotion of liver carcinogenesis (Lena Ohlson). Fakultetsopponent:
Bertha A Brodin.
Torgny Windahl
10 juni, kirurgi, Örebro universitet, kl 13.00, Wilandersalen,
Universitetssjukhuset, Örebro: Clinical aspects of lichen sclerosus
and squamous cell carcinoma of the penis (Torgny Windahl).
Fakultetsopponent: Peter Ekman.
Linda Björkhem Bergman
11 juni, patologi, Karolinska institutet, kl 09.15, Birkeaulan 1,
plan 5, F-huset, Karolinska Universitetssjukhuset Huddinge:
Thioredoxin reductase and selenium in carcinogenesis and multidrug
resistance (Linda Björkhem Bergman). Fakultetsopponent: Björn
Åkesson.
Maria Held
11 juni, epidemiologi, Karolinska institu-tet, kl 09.00,
Petrénsalen, Nobels väg 12B: Epidemiological studies of Helicobacter
pylori and its relation to cancer and precancer-ous lesions in the
upper gastrointestinal tract (Maria Held). Fakultetsopponent: Timo
Ko-sunen, Finland.
Fahimeh Rahnama
11 juni, cancerbiologi, Karolinska institutet, kl 09.00, hörsalen,
plan 4, Novum: Molecular complexities of patched signaling in cancer
development (Fahimeh Rahnama). Fakultetsopponent: Allen Bale, USA.
Andrea Vlastos Franzén
11 juni, experimentell onkologi, Karolinska institutet, kl 09.00,
föreläsningssalen, Cancer Centrum Karolinska, Karolinska
Universitetssjukhuset Solna: Murine polyoma-virus VP1 virus-like
particles as vectors for gene therapy and as vaccines against
poly-omavirus infection and tumors (Andrea Vlastos Franzén).
Fakultetsopponent: Mikael Jondal.
MAJ 2004
Karin
Leifland
7 maj, diagnostisk radiologi, Karolinska institutet, kl 09.00,
Skandiasalen, Astrid Lindgrens barnsjukhus, Karolinska
Universitetssjukhuset Solna: Comparison of stereotactic fine needle
aspiration biopsy and core needle biopsy in breast lesions (Karin
Leifland). Fakultetsopponent: Olof Jarlman.
Åsa Liljegren Sundberg
8 maj, biomedicinsk strålningsvetenskap, Uppsala universitet, kl
09.15, Rudbecksalen, Rudbecklaboratoriet, Dag Hammarskjölds väg 20:
Tumour targeting using radiolabelled EGF conjugates: Preclinical
studies (Åsa Liljegren Sundberg). Fakultetsopponent: Gregory P
Adams, USA.
Marina Protopopova
7 maj, onkologi/experimentell onkologi, Karolinska institutet, kl
09.30, föreläsningssalen, MTC: Modulation of activity of the tumour
suppressor p53 by small molecules and damaged DNA (Marina
Protopopova). Fakultetsopponent: Giannino Del Sal, Italien.
Owe Lundberg
14 maj, kirurgi, Umeå universitet, kl 13.00, sal B, 9 tr,
Tandläkarhögskolan: Laparoscopy and tumour growth (Owe Lundberg).
Fakultetsopponent: Dag Arvidsson.
Susanna
Ekholm-Reed
14 maj, patologi, cytologi och experimentell patologi, Karolinska
institutet, kl 13.00, Radiumhemmets föreläsningssal: The role of
cyclin E in cell cycle regulation and genomic instability (Susanna
Ekholm-Reed). Fakultetsopponent: Göran Landberg.
Mattias Berglund
18 maj, onkologi, Uppsala universitet, kl 13.15, Rudbecksalen,
Rudbecklaboratoriet, Dag Hammarskjölds väg 20: Molecular
characterization of diffuse large B-cell lymphoma and aspects of
transformation (Mattias Berglund). Fakultetsopponent: Ingemar
Ernberg.
APRIL 2004
Patrik Hentschke
16 april, klinisk immunologi, Karolinska institutet: Anti-tumour
effect in solid tumours, tolerance and immune reconstitu-
tion after allogeneic haematopoietic stem cell transplantation
(Patrik Hentschke). Fakultets-opponent: Jan W Gratama,
Nederländerna.
Kerstin Jönsson Videsäter
23 april, medicinsk hematologi, Karolinska institutet, kl 09.00,
föreläsningssalen, M63, Karolinska Universitetssjukhuset Huddinge:
Expression of multidrug resistance genes and proteins and effect of
selenite in anthracycline-resistant human tumor cell lines (Kerstin
Jönsson Videsäter). Fakultetsopponent: Johan Hansson.
Sveinbjörn Kristjánsson
23 april, onkologi/experimentell onkologi, Karolinska institutet, kl
10.00, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: Skin cancer prevention. Readiness to
change sun-related behaviours (Sveinbjörn Kristjánsson).
Fakultetsopponent: Timo Hursti.
Takayuki Ueno
23 april, onkologi/experimentell onkologi, Karolinska institutet, kl
09.30, föreläsningssalen, CCK, Karolinska Universitetssjukhuset
Solna: Analyses of the expression and function of the aspartic
protease napsin (Takayuki Ueno). Fakultetsopponent: Emanuelle
Liaudet-Coopman, Frankrike.
Ana Maria Rojas
28 april, onkologi, Umeå universitet, kl 09.00, sal 244, byggnad 7,
Norrlands Universitetssjukhus: ARCON in experimental and clinical
radiotherapy (Ana Maria Rojas). Fakultetsopponent: René Olivier
Mirimanoff, Schweiz.
Fredrik Erlandsson
28 april, patologi, cytologi, experimentell patologi, Karolinska
institutet, kl 09.00, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: Immunofluorescence studies on the cell
cycle expression of cyclin A and cyclin E (Fredrik Erlandsson).
Fakultetsopponent: Christer Busch.
Aleksi Lähdesmäki
29 april, klinisk immunologi, Karolinska institutet, kl 09.30, sal
9Q, Alfred Nobels allé 8, Karolinska Universitetssjukhuset
Huddinge: Functional analysis of ATM with relevance for primary
immunodeficiency and tumor formation (Aleksi Lähdesmäki).
Fakultetsopponent: Carmen Fernández.
Karin Rennstam
30 april, experimentell onkologi, Lunds universitet, kl 09.00,
föreläsningssalen, onkologiska kliniken, Universitetssjukhuset i
Lund: Molecular cytogenetics in sporadic breast cancer (Karin
Rennstam). Fakultetsopponent: Peter Lichter, Tyskland.
MARS 2004
Roger Tell
19 mars, onkologi/experimentell onko-logi, Karolinska institutet, kl
09.15, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: Description and prediction of clinical
radiosensitivity: emphasis on normal tissue reactions (Roger Tell).
Fakultetsopponent: Ingela Turesson.
Lotta Hansson
12 mars, onkologi/experimentell onko-logi, Karolinska institutet, kl
09.15, Radiumhemmets föreläsningssal, Karolinska
Universitetssjukhuset Solna: Natural and induced idiotype immunity
in patients with multiple myeloma (Lotta Hansson).
Fakultetsopponent: Anders Waage, Norge.
Malin Bergman
5 mars, onkologi, Linköpings universitet, kl 09.00, aulan,
Administrationshuset, Universitetssjukhuset: Genetic polymorphism
and breast cancer risk in young women (Malin Bergman).
Fakultetsopponent: Helena Jernström.
Karin Ahlberg
12 mars, omvårdnad, Göteborgs universitet: Cancer-related fatigue –
experience and outcome (Karin Ahlberg). Fakultetsopponent: Carol
Tishelman.
Thomas Lindahl
26 mars, onkologi/experimentell onko-logi, Karolinska institutet, kl
09.30, Radiumhemmets föreläsningssal, Karolinska
Uni-versitetssjukhuset Solna: Prognostic markers in breast cancer
associated with cell cycle control, proliferation and angiogenesis
(Thomas Lindahl). Fakultetsopponent: Mårten Fernö.
Louise Olsson
26 mars, klinisk epidemiologi (rättelse), Karolinska institutet, kl
14.00, samlingssalen, psykiatriska kliniken, ingång 29,
Centrallasarettet Västerås (videoöverföring till Lennart
Nilssonsalen, Nobels väg 15A, Karolinska institutet): Early
detection of colorectal cancer (Louise Olsson). Fakultetsopponent:
Tom Öresland.
FEBRUARI 2004
Hong Li
27 februari, cell- och molekylärbiologi, Karolinska
institutet, kl
09.30, auditoriet, cell- och molekylärbiologiska
institutionen,
Berzelius väg 21: Studies of VEGF-B and novel PDGFs in
tumorigenesis
and angiogenesis (Hong Li). Fakultetsopponent: Sven Påhlman.
Hanjing Xie
19 februari, klinisk farmakologi, Karolinska institutet, kl 09.00,
föreläsningssal R64, Karolinska Universitetssjukhuset Huddinge:
Pharmacogenetic and pharmacokinetic studies of cyclophosphamide in
cell, animal and human (Hanjing Xie). Fakultetsopponent: Gilles
Vassal, Frankrike.
Annelie Liljegren
13 februari, medicinsk genetik, Karolinska institutet, kl 10.00,
Radiumhemmets föreläsningssal, Karolinska Universitetssjukhuset
Solna: Hereditary colorectal cancer: predisposition and prevention
(Annelie Liljegren). Fakultetsopponent: Rune Sjödahl.
Zakari Einbeigi
6 februari, onkologi, Göteborgs universitet, kl 09.00,
föreläsningssal Ivan Ivarsson, Medicinaregatan 3 5: Hereditary
breast and ovarian cancer in western Sweden with a special focus on
BRCA1 3171ins5 mutation (Zakari Einbeigi). Fakultetsopponent: Per
Hall.
JANUARI 2004
Gunnar Larfors
9 januari, epidemiologi, Karolinska institutet: Pregnancy related
risk factors for breast cancer (Gunnar Larfors). Fakultetsopponent:
Janet Daling, USA.
Janna Dejmek
9 januari, experimentell patologi, Lunds universitet: Role of Wnt-5a
in breast cancer (Janna Dejmek). Fakultetsopponent: Marc van de
Wetering, Nederländerna.
Tetyana Levchenko
16 januari, onkologi/experimentell onkologi, Karolinska institutet,
kl 10.00, Radiumhemmets föreläsningssal, Karolinska sjukhuset: The
role of angiomotin in angiogenesis (Tetyana Levchenko).
Fakultetsopponent: Marsha A Moses, USA.
Christian Kamp Nielsen
23 januari, experimentell patologi, Lunds universitet, kl 09.15,
föreläsningssalen, patologen, ingång 78, Universitetssjukhuset MAS,
Malmö: Regulation and function of the human leukotriene D4 receptor
CysLT1 in epithelial cells and colon cancer (Christian Kamp
Nielsen). Fakultetsopponent: Charles Brink, Frankrike.
Lorenzo Richiardi
30 januari, epidemiologi, Karolinska institutet, kl 09.15,
Samuelssonsalen, Scheelelaboratoriet, Tomtebodavägen 6: New evidence
on germ-cell testicular cancer aetiology (Lorenzo Richiardi).
Fakultetsopponent: Henrik Møller, England.
DECEMBER 2003
Christian Andersson
17 december, medicinsk och fysiologisk kemi, Göteborgs universitet,
kl 09.00, föreläsningssal Nils Nilsson, Medicinaregatan 3:
Expression and novel function of CD43 in colon cancer cells
(Christian Andersson). Fakultetsopponent: John Hilkens,
Nederländerna.
Szilvia Mosolits
18 december, immunologi, tumörimmunologi, Karolinska institutet, kl
09.30, föreläsningssalen, CCK, plan 0, Karolinska sjukhuset: Natural
and induced immunity against the tumour-associated antigen, Ep-CAM
(Szilvia Mosolits). Fakultetsopponent: Antonio Pezzutto, Tyskland.
Henrik Lindman
20 december, onkologi, Uppsala universitet, kl 09.15, Rudbecksalen,
Rudbecklaboratoriet: Individually tailored toxicity-based
chemotherapy: Studies on patients with primary and metastatic breast
cancer (Henrik Lindman). Fakultetsopponent: Bo Nordenskjöld.
Anna Bergsmedh
5 december, onkologi/experimentell onko-logi, Karolinska institutet,
kl 10.00, Radiumhemmets föreläsningssal, Karolinska sjukhuset:
Horizontal gene transfer by uptake of apoptotic bodies (Anna
Bergsmedh). Fakultetsopponent: Carrie Rinker-Schaeffer, USA.
Andreas Ekborn
5 december, öron-, näs- och halssjukdomar/audiologi, Karolinska
institutet, kl 09.00, öron-, näs- och halsklinikens föreläsningssal,
A6:02, Karolinska sjukhuset: Cis-platin induced ototoxicity.
Pharmacokinetics, prediction and prevention (Andreas Ekborn).
Fakultetsopponent: Jukka Ylikoski, Finland.
Ulrik Lindforss
5 december, kirurgi, Karolinska institutet, kl 09.00,
föreläsningssalen, plan 4, Alfred Nobels allé 8, Huddinge
Universitetssjuk-hus: On the clinical value of genetic analysis in
colorectal cancer patients (Ulrik Lindforss). Fakultetsopponent:
Roger Stenling.
NOVEMBER 2003
Theocharis Panaretakis
28 november, onkologi och experimentell onkologi, Karolinska
institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska
sjukhuset: On the pro-apoptotic mechanisms of the antitumor drugs
doxorubicin and interferon-a (Theocharis Panaretakis).
Fakultetsopponent: Sven Påhlman.
Pauli Vaittinen
28 november, molekylär epidemiologi, Karolinska institutet, kl
09.30, seminarierummet, plan 6, CNT, hus F, Novum, Huddinge: Risk
characterization of familial cancer using the Swedish family-cancer
data-base with a special reference to breast cancer (Pauli
Vaittinen). Fakultetsopponent: Paul Dickman.
Per Frisk
21 november, pediatrik, Uppsala universitet, kl 09.15, Rosénsalen,
Akademiska barnsjukhuset: Late effects of autologous bone marrow
transplantation in childhood (Per Frisk). Fakultetsopponent: Göran
Elinder.
Julius Hreinsson
21 november, obstetrik och gynekologi, Karolinska institutet, kl
09.00, föreläsningssalen, B64, Huddinge Universitetssjukhus:
Preservation of fertility through cryopreservation and in vitro
maturation of human ovarian follicles and oocytes (Julius
Hreinsson). Fakultetsopponent: Per Olof Janson.
Ingrid Idvall
21 november, patologi, Lunds universitet, kl 09.15,
Medicinhistoriska museet, Berga-liden 20, Helsingborg: Ductal
carcinoma in situ of the breast. Histopathological and cell
biological factors; their relationship tomode of detection and to
subsequent ipsilateral and contralateral tumours (Ingrid Idvall).
Fakultetsopponent: Björn Risberg, Norge.
Bibbi Thomé
21 november, vårdvetenskap, särskilt omvårdnad, Lunds universitet,
kl 09.00, hörsal 1, institutionen för omvårdnad: Living with cancer in old age.
Quality of life and meaning (Bibbi Thomé). Fakultetsopponent:
Britt-Marie Ternestedt.
Anna Milberg
13 november, palliativ medicin, Linköpings universitet, kl 09.00,
Victoriasalen, Universitetssjukhuset: Family members experience of
palliative home care (Anna Milberg). Fakultetsopponent: Christina Bolund.
Weimin Ye
14 november, epidemiologi, Karolinska institutet, kl 09.00,
föreläsningssal Bertil, Berzelius väg 3: Aspects of gastroesophageal
reflux and risk for esophageal cancer. An epidemiological approach
(Weimin Ye). Fakultetsopponent: Thomas L Vaughan, USA.
OKTOBER 2003
Kristina Elfgren
24 oktober, obstetrik och gynekologi, Karolinska institutet, kl 09.00,
föreläsningssal 9Q, Alfred Nobels Allé 8: Longitudinal studies of human
papillomavirus infection with special reference to screening for cervical
cancer and treatment of CIN (Kristina Elfgren). Fakultetsopponent: Charles
Lacey, England.
Mikael Machado
17 oktober, kirurgi, Karolinska institutet, kl 09.00, Bringsalen, 1 tr,
Ersta Hotell & Konferens, Erstagatan 1K: Studies of prognostic and
functional outcomes in surgery for rectal cancer (Mikael Machado).
Fakultetsopponent: Tom Öresland.
Marju Dahmoun
17 oktober, obstetrik och gynekologi, Umeå universitet, kl 09.15, hörsal
E04, byggnad 6E, Norrlands Universitetssjukhus: Apoptosis, proliferation,
and sex steroid receptors in endometrium and endometrial carcinoma (Marju
Dahmoun). Fakultetsopponent: Seija Grenman, Finland.
Marianne Hammarsund
17 oktober, onkologi/experimentell onkologi, Karolinska institutet, kl
09.30, Radiumhemmets föreläsningssal, Karolinska sjukhuset: Genetic changes
in lymphoid leukemia (Marianne Hammarsund). Fakultetsopponent: Göran
Stenman.
Daniel Brattström
4 oktober, onkologi, Uppsala universitet, kl 09.15, Skoogsalen, kliniken för
onkologi, Akademiska sjukhuset: Angiogenesis related markers in non-small
cell lung cancer (Daniel Brattström). Fakultetsopponent: Torgny Rasmusen.
Hildur Einarsdottir
10 oktober, diagnostisk radiologi, Karolinska institutet, kl 09.00,
Skandiasalen, Astrid Lindgrens barnsjukhus, Karolinska sjukhuset: Imaging of
soft tissue tumors (Hildur Einarsdottir). Fakultetsopponent: Kjell Jonsson.
Magnus Törnblom
10 oktober, urologi, Karolinska institutet,
kl 09.00, föreläsningssal C1-87, Huddinge Universitetssjukhus: The
diagnostic perform-ance of prostate-specific antigen (PSA) in early
detection of prostata cancer: Consid-erations of sensitivity, specificity,
lead-time and survival (Magnus Törnblom). Fakultets-opponent: Bo-Johan
Norlén.
SEPTEMBER 2003
Ulrika Bäckman
26 september, medicinsk cellbiologi, Uppsala universitet, kl 13.15, sal B21,
BMC: Treatment of experimental neuroblastoma with angiogenic inhibitors
(Ulrika Bäckman). Fakultetsopponent: Sven Påhlman.
Richard Bränström
26 september, klinisk cancerepidemiologi, Karolinska institutet, kl 09.30,
Radiumhemmets föreläsningssal, Karolinska sjukhuset: Skin cancer prevention.
Behaviours related to sun exposure and early detection (Richard Bränström).
Fakultetsopponent: Christian Ingvar.
Eva Fernebro
26 september, onkologi, Lunds universitet, kl 09.00, föreläsningssalen,
onkologiska kliniken, Universitetssjukhuset i Lund: Rectal cancer: Tumor
biology and prognostic markers (Eva Fernebro). Fakultetsopponent: Rune
Sjödahl.
Thomas Strömberg
27 september, patologi, Uppsala universitet, kl 13.15, Rudbecksalen,
Rudbecklaboratoriet: The regulation of growth and survival in human multiple
myeloma cells by IGF-1 receptor signaling (Thomas Strömberg).
Fakultetsopponent: Anders Waage, Norge.
Kaoru Fujioka
5 september, experimentell onkologi, Karolinska institutet, kl 09.30,
föreläsningssalen, Radiumhemmet, Karolinska sjukhuset: Centrosome
aberrations and tumor development (Kaoru Fujioka). Fakultetsopponent:
Albrecht Reith, Norge.
Mehmet Uzunel
5 september, allogen stamcellstransplantation, Karolinska institutet, kl
09.00, Birke-aulan, F51, Huddinge Universitetssjukhus: The methodology and
significance of minimal residual disease detection after alloge-netic stem
cell transplantation (Mehmet Uzunel). Fakultetsopponent: Nick Cross,
England.
AUGUSTI 2003
Kerstin Moberg
29 augusti, medicinsk radiologi, Karolinska institutet, kl 09.00, aulan,
plan 6, Södersjukhuset: Incidence and interval breast cancers in
retrospective assessment (Kerstin Moberg). Fakultetsopponent: Peter B Dean,
Finland.
JUNI 2003
Åsa Svensson
4 juni, medicinsk cellbiologi, Uppsala universitet, kl 09.15,
föreläsningssal B21, BMC: Application of a new logic to old drugs:
angiogenesis inhibition of neuroblastoma (Åsa Svensson). Fakultetsopponent:
Per Kogner.
Grazyna Alicja Stanczuk
4 juni, internationell hälsa, Karolinska institutet, kl 09.00, aulan, plan
2, Norrbackabyggnaden, Karolinska sjukhuset: Cervical cancer in Zimbabwe:
viral and host factors. Studies on pathogenesis of cervical cancer in
Zimbabwe with special reference to type-specific human papillomavirus (HPV)
infection and human cytokine gene polymorphisms (Grazyna Alicja Stanczuk).
Fakultets-opponent: Eva Rylander.
Amir Sherif
6 juni, urologi, Uppsala universitet, kl 09.15, Rudbecksalen,
Rudbecklaboratoriet: Experimental diagnostics and therapeutics of invasive
bladder cancer (Amir Sherif). Fakultetsopponent: Michael J Droller, USA.
Bengt Isaksson
6 juni, kirurgi, Karolinska institutet, kl 09.00, hörsalen, plan 4, Novum,
Huddinge Universitetssjukhus: Insulin resistance in pancreatic cancer (Bengt
Isaksson). Fakultetsopponent: Richard Bell, USA.
Irina Holodnuka
10 juni, tumörbiologi, Karolinska institutet, kl 09.30, föreläsningssalen,
MTC, Nobels väg 16: A microcell hybrid based elimination test to identify
human chromosome 3 regions that antagonize tumor growth (Irina Holodnuka).
Fakultetsopponent: Charles H C M Buys, Nederländerna.
Miklós Gulyás
11 juni, cellbiologi, Göteborgs universitet, kl 09.00, föreläsningssal Tor Bjurström, Medicinaregatan 3B: Gene therapy of neuroblastoma (Yvonne Arvidsson). Fakultetsopponent: Per Kogner.
13 juni, patologi, Karolinska institutet, kl 09.00, Birkeaulan 1, F51,
Huddinge Universitetssjukhus: Mesothelial differentiation, mesothelioma and
tumor markers in serous cavities (Miklós Gulyás). Fakultetsopponent: Gert
Auer.
Jian Liu
13 juni, molekylär tumörbiologi, Karolinska institutet, kl 13.00,
föreläsningssal E525, MTC, Nobels väg 16: Deletion mapping of human 3p in
major epithelial types of cancer and fine localization of candidate tumor
suppressor genes (Jian Liu). Fakultetsopponent: Ola Myklebost, Norge.
MAJ 2003
Kjell Ivarsson
10 maj, kirurgi, Lunds universitet, kl 09.15, Segerfalksalen, Wallenberg
Neurocentrum, BMC, Sölvegatan 17: Interstitial laser thermotherapy (ILT) of
an adenocarcinoma implanted into rat liver methodology and effects (Kjell
Ivarsson). Fakultetsopponent: Joar Svanvik.
Anna Ljungkvist
16 maj, onkologi, Umeå universitet, kl 13.00, sal 244, byggnad 7, Norrlands
Universitetssjukhus: Imaging the tumor microenvironment: The dynamics and
modification of hypoxia (Anna Ljungkvist). Fakultetsopponent: Peggy L Olive,
Kanada.
Andrei Alimov
16 maj, experimentell patologi, Karolinska institutet, kl 09.30,
föreläsningssalen, Cancercentrum, Karolinska sjukhuset: Molecular genetic
aspects of renal cell carcinoma development (Andrei Alimov).
Fakultetsopponent: Göran Landberg.
Irene Mattisson
16 maj, experimentell medicin, Lunds universitet, kl 09.00, Jubileumsaulan,
Medicinskt forskningscentrum, ingång 59, Universitetssjukhuset MAS, Malmö:
Dietary fat as an exposure in epidemiological studies. Observation in the
Malmö diet and cancer cohort (Irene Mattisson). Fakultetsopponent: Wulf
Becker.
Göran Hesselager
19 maj, patologi, Uppsala universitet, kl 09.15, Rudbecksalen,
Rudbecklaboratoriet: A short thesis about growth factors in gliomas (Göran
Hesselager). Fakultetsopponent: Eric C Holland, USA.
Nicole Basset-Seguin
22 maj, patologi, Uppsala universitet, kl 09.00, Fåhraeussalen: Analysis of
sun-damaged skin and epidermal p53 clones (Helena Bäckvall).
Fakultetsopponent: Nicole Basset-Seguin, Frankrike.
Gunnar Myrdal
22 maj, kirurg, särskilt toraxkirurgi, Uppsala universitet, kl 09.15,
Robergsalen, ingång 40, Akademiska sjukhuset: Lung cancer: Epidemiological
and clinical studies with special reference to surgical treatment (Gunnar
Myrdal). Fakultetsopponent: Bengt Bergman.
Jessica Ekedahl
23 maj, medicinsk strålningsbiologi, Karolinska institutet, kl 09.30,
Radiumhemmets föreläsningssal, Karolinska sjukhuset: Apoptotic signaling in
lung carcinoma cells with focus on mechanisms of radioresistance
(Jessica Ekedahl). Fakultetsopponent: Klaus-Michael Debatin, Tyskland.
Hajnalka Kiss
23 maj, tumörbiologi, Karolinska institutet, kl 09.30, föreläsningssal
Rockefeller, Nobels väg 11: Characterization of a puta-tive tumor suppressor
region identified by the elimination test on human 3p21.3 (Hajnalka Kiss).
Fakultetsopponent: Pierre Åman.
Anna Martling
23 maj, kirurgi, Karolinska institutet, kl 09.00, Nanna Svartz auditorium,
Karolinska sjukhuset: Rectal cancer: Staging, radiotherapy and surgery
(Anna Martling). Fakultets-opponent: Svante Nordgren.
Niina Veitonmäki
23 maj, cell- och tumörbiologi, Karolinska institutet, kl 13.00, sal E525,
MTC: Angiostatic mechanisms of endogenous angiogenesis inhibitors (Niina
Veitonmäki). Fakultetsopponent: Judah Folkman, USA.
Gustav Ullenhag
24 maj, onkologi, Uppsala universitet, kl 09.15, sal IV, Universitetshuset:
Vaccine therapy of colorectal cancer patients with
tumor associated antigens (Gustav Ullenhag). Fakultetsopponent: Torgny
Stigbrand.
Håkan Hedtjärn
27 maj, medicinsk radiofysik, Linköpings universitet, kl 09.00,
Berzeliussalen, plan 9, Universitetssjukhuset: Dosimetry in brachytherapy.
Application of the Monte Carlo method to single source dosimetry and use
of correlated sampling for accelerated dose calculations (Håkan Hedtjärn).
Fakultetsopponent: David Rogers, Kanada.
Katarina Rask
27 maj, fysiologi, Göteborgs universitet, kl 09.00, föreläsningssal Gösta
Sandels, K2403: Tumor progression in the ovary and colon. The interaction of
Wnt-signaling, transcription and formation of prostaglandins (Katarina
Rask). Fakultetsopponent: Mark Hull, England.
Peter Berg
28 maj, dermatologi och venereologi, Karolinska institutet, kl 08.45,
Welandersalen, hudkliniken, Karolinska sjukhuset: Malignant melanoma in
children and adolescents (Peter Berg). Fakultetsopponent: Olle Larkö.
Ebba Bråkenhielm
28 maj, tumörbiologi, Karolinska institutet, kl 10.00, föreläsningssalen,
MTC, Theorells väg 1: Angiogenesis in obesity and cancer (Ebba Bråkenhielm).
Fakultetsopponent: Rudolph Busse, Tyskland.
Ulla Forssén
28 maj, epidemiologi, Karolinska institutet, kl 09.15, Samuelssonsalen,
Tomtebodavägen 6: Extremely low frequency magnetic fields and breast cancer
(Ulla Forssén). Fakultetsopponent: Leeka Kheifets, Schweiz.
Unnur Anna Valdimarsdóttir
28 maj, onkologi/experimentell onkologi, Karolinska institutet, kl 09.15,
föreläsningssal Rockefeller, IMM: The loss of a husband to cancer:
Additional and avoidable psychological traumata (Unnur Anna
Valdimarsdóttir). Fakultetsopponent: Colin Murray Parkes, England.
Ylva Hedberg
30 maj, patologi, Umeå universitet, kl 09.00, hörsal Betula, by 6M: Cell
cycle regulation in human renal cell carcinoma (Ylva Hedberg).
Fakultetsopponent: Ulf Bergerheim.
APRIL 2003
Niklas Loman
24 april, onkologi, Lunds universitet, kl 09.15, onkologiska klinikens
föreläsningssal, Universitetssjukhuset i Lund: Clinical aspects of
hereditary breast cancer (Niklas Loman). Fakultetsopponent: Arne Wallgren.
Maria Åström
25 april, hematologi, Karolinska institutet, kl 13.00, Wilandersalen,
Universitetssjuk-huset, Örebro: Prognosis in acute myeloid leukemia and
influence of monocytic markers. Epidemiological, clinical and experimental
studies (Maria Åström). Fakultetsopponent: Finn Wisløff, Norge.
Lars Forsberg
11 april, medicinsk genetik, Karolinska institutet, kl 09.00, lilla
föreläsningssalen, Astrid Lindgrens barnsjukhus, Karolinska sjukhuset:
Localization and characterization of genes involved in parathyroid tumor de-
velopment (Lars Forsberg). Fakultetsopponent: Gunnar Westin.
Kristina Viktorsson
11 april, experimentell onkologi, Karolinska institutet, kl 09.30,
Radiumhemmets föreläsningssal, Karolinska sjukhuset: On the role of SAP
kinase pathways in cellular responses to cancer treatment (Kristina
Viktorsson). Fakultetsopponent: Ulf Brunk.
Laura Settimi Dionisi
8 april, yrkes- och miljömedicin, Linköpings universitet, kl 13.00, aulan,
Hälsans Hus, Universitetssjukhuset: Cancer risks and immunological effects
in agriculture (Laura Settimi Dionisi). Fakultetsopponent: Helge Kjuus,
Norge.
Camilla Persson
4 april, molekylär cellbiologi, Uppsala universitet, kl 13.15, sal B42,
Biomedicinskt centrum: Protein tyrosine phosphatases as regulators of
receptor tyrosine kinases (Camilla Persson). Fakultetsopponent: Niels Peter
Møller, Danmark.
Magnus Rizell
4 april, kirurgi, Göteborgs universitet, kl 13.00, samlingssalen,
matsalsbyggnaden, Sahlgrenska Universitetssjukhuset: Treatment of malignant
tumors with histamine clinical and experimental studies (Magnus Rizell).
Fakultetsopponent: Christian Ingvar.
Barbro Boström
4 april, anestesiologi och intensivvård, Lunds universitet, kl 09.00,
Malcussalen, Högskolan i Halmstad: Acute postoperative and cancer-related
pain management. Patients¹ experiences and perceptions in relation to
heath-related quality of life and the multidimensionality of pain (Barbro
Boström). Fakultetsopponent: Björn Sjöström.
MARS 2003
Helene Sjögren
7 mars, patologi, Göteborgs universitet, kl 13.00, patologens
föreläsningssal, Sahlgrenska Universitetssjukhuset: Studies on the molecular
pathogenesis of extraskeletal myxoid chondrosarcoma and other cartilage tumors
(Helene Sjögren). Fakultetsopponent: Janusz Limon, Polen.
Anna Beskow
21 mars, medicinsk genetik, Uppsala universitet, kl 09.15, Rudbecksalen: Genetic risk factors for cervical carcinoma in situ (Anna Beskow). Fakultetsopponent: Peter L Stern, England.
Stefan Johnsson
21 mars, radiofysik, Lunds universitet, kl 10.00, föreläsningssalen, onkologiska kliniken, Universitetssjukhuset i Lund: De-
velopment and evaluation of an independent system for absorbed dose calculations in radiotherapy (Stefan Johnsson). Fakultets-opponent: Hans Svensson.
FEBRUARI 2003
Annette Hansson
28 februari, toxikologi, Karolinska institutet, kl 09.15, föreläsningssalen, MTC, Theorells väg 1: Modeling of multi-step oral carcinogenesis in vitro: assessment of growth, differentiation and apoptosis markers (Annette Hansson). Fakultetsopponent: Johan Wennerberg.
Aleksandra Mandi´c
28 februari, onkologi/patologi, Karolinska institutet, kl 09.30, Radiumhemmets föreläsningssal, Karolinska sjukhuset: Elucidation of pro-apoptotic signaling induced by cis-platin (Aleksandra Mandi´c). Fakultetsopponent: Carl-Henrik Heldin.
Maria Sundbäck
28 februari, immunbiologi/tumörimmunologi, kl 09.30, föreläsningssalen vid Cancer center Karolinska, plan 0, Karolinska sjukhuset: Vaccine strategies based on mycobacterial heat shock protein 65 (Maria Sundbäck). Fakultetsopponent: Catharina Svanborg.
JANUARI 2003
Hans Thulesius
8 januari, allmänmedicin, Lunds universitet: Balancing cancer from a primary care perspective. Diagnosis, posttraumatic stress, and end-of-life care (Hans Thulesius). Fakul-tetsopponent: Bengt Mattsson.
Jingfeng Li
16 januari, cell- och tumörbiologi, Karolinska institutet, kl 14.00, Rockefellersalen, Nobels väg 11: Development of new ap-
proaches for tumor suppressor genes identification (Jingfeng Li). Fakultetsopponent: Magnus Nordenskjöld.
Elena Kashuba
17 januari, tumörbiologi, Karolinska institutet, kl 10.00, föreläsningssalen, MTC, Nobels väg 16: Identification of EBNA binding cellular proteins, using yeast two-hybrid system (Elena Kashuba). Fakultetsopponent: Paul Farrell, England.
Anna-Karin Ström
17 januari, patologi, Göteborgs universitet, kl 09.00, patologens föreläsningssal, Sahlgrenska Universitetssjukhuset: Studies of PLAG1 and HMGIC fusion oncogenes in human tumors (Anna-Karin Ström). Fakultetsopponent: Thoas Fioretos.
Åsa Holgersson
24 januari, medicinsk strålningsbiologi, Karolinska institutet, kl 09.00, Radiumhemmets föreläsningssal, Karolinska sjukhuset: DNA-dependent protein kinase in normal and malignant cells. With special reference to anti-tumour agent sensitivity (Åsa Holgersson). Fakultetsopponent: Börje Andersson, USA.
Tomas Riman
24 januari, medicinsk epidemiologi, Karolinska institutet, kl 09.00, Samuelssonsalen, Scheelelaboratoriet, MBB, Tomtebodavägen 6: An epidemiologic study of epithelial ovarian malignancies: with a focus on hormone-related factors (Tomas Riman). Fakultetsopponent: Bernard L Harlow, USA.
DECEMBER 2002
Parviz Behnam-Motlagh
6 december, klinisk kemi, Umeå
universitet, kl 09.30, föreläsningssal 244, onkologi, 2 tr, byggnad 7:
Antiemetic drug interference with anticancer drug cytotoxicity.
Fakultetsopponent: Curt Peterson.
Tomas Barkhem
6 december, molekylär endokrinologi,
Karolinska institutet, kl 09.00, föreläsningssalen, Novum, plan 4, Huddinge:
Molecular mechanisms of estrogen and antiestrogen action. Fakultetsopponent:
Peter Kushner, USA.
Max van Hogerlinden
6 december, cancerbiologi, Karolinska
institutet, kl 09.30, seinarierummet, institutionen för medicinsk näringslära,
plan 5, Novum, Huddinge: NF-kB in epidermal signal transduction and tumor
development. Fakultetsopponent: Thomas D Gilmore, USA.
Johan Dixelius
6 december, molekylär medicin, Uppsala
universitet, kl 09.15, Rudbecklaboratoriet, Dag Hammarskjölds väg 20:
Endothelial differentiation and angiogenesis regulation . Fakultetsopponent:
Björn Olsen, USA.
Sofia Thelin-Järnum
10 december, tumörimmunologi, Lunds universitet, kl 13.00, Rune Grubbsalen, BMC, Sölvegatan 19: Molecular studies of genetic changes in myxoid and round cell liposarcomas (Sofia Thelin-Järnum). Fakultetsopponent: Jan Dumanski.
Kristina Lindsten
12 december, cell- och tumörbiologi, Karolinska institutet, kl 09.00, sal Adam, Berzelius väg 3: Functional studies of the ubiquitin-proteasome system using GFP-based reporters (Kristina Lindsten). Fakultetsopponent: Dieter Wolf, Tyskland.
Veli Söderlund
13 december, diagnostisk radiologi, Karolinska institutet, kl 09.00, lilla föreläsningssalen, Astrid Lindgrens barnsjukhus, Karolinska sjukhuset: Combined radiology and cytology in the diagnosis of bone lesions. A study of 494 patients (Veli Söderlund). Fakultetsopponent: Örjan Berlin.
Dan Ribom
14 december, neurologi, Uppsala universitet, kl 13.15, Rudbecksalen: In search of prognostic factors in grade 2 gliomas (Dan Ribom). Fakultetsopponent: Tommy Bergenheim.
Mikael von Euler
19 december, pediatrisk vetenskap, Karolinska institutet, kl 09.00, Skandiasalen, Astrid Lindgrens barnsjukhus, plan 1, Karolinska sjukhuset: Mechanisms influencing activation and survival of normal and malignant lymphoid cells in the testis (Mikael von Euler). Fakultetsopponent: Anders Bergh.
Anne-Marie Levin Jakobsen
19 december, patologi, Göteborgs universitet, kl 13.00, patologens föreläsningssal, Sahlgrenska Universitetssjukhuset: Vesicle proteins as markers for neuroendocrine tumours (Anne-Marie Levin Jakobsen). Fakultetsopponent: Lars Grimelius.
Bo Lindberg
20 december, diagnostisk radiologi, Karolinska institutet, kl 09.00, Birkeaulan 1, Huddinge Universitetssjukhus: Endoscopic methods for detecting malignancy in patients with ulcerative colitis and primary sclerosing cholangitis (Bo Lindberg). Fakultetsopponent: Frans-Thomas Fork.
Anna Åleskog
20 december, klinisk farmakologi, Uppsala universitet, kl 13.15, ingång 50, Akademiska sjukhuset: Application of in vitro-
chemosensitivity testing for evaluation of new cytotoxic drugs in chronic lymphocytic leukaemia (Anna Åleskog). Fakultetsopponent: Jan Liliemark.
Eva Andersson
20 december, medicin, särskilt yrkesmedicin, Göteborgs universitet, kl 09.00, aulan, Sahlgrenska Universitetssjukhuset: Asthma and cancer among pulp and paper mill workers (Eva Andersson). Fakultetsopponent: Per Gustavsson.